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Scientific Programme
Friday, 3 July 2020
0900-1030

Oral Abstracts Presentation
Chairperson: Ngai-yin Chan
Judges: Joseph YS Chan, Ngai-yin Chan, Suet-ting Lau
Risk of ventricular arrhythmia in improved left ventricular ejection fraction in
implantable cardioverter-defibrillator for primary prevention
Total aortic arch replacement and frozen elephant trunk: mid term and
second stage surgery outcomes
What demographic factors influence participation in a randomised controlled trial
on prehabilitation for cardiac surgery?
Effect of Homocysteine on the KCa channel Family in Human Internal Mammary Artery
Influenza Activity and ST-segment Elevation Myocardial Infarction Incidence
in Hong Kong
Long term survival of one hundred left ventricular assist device recipients in Hong Kong
Early clinical experience with the rapid deployment Intuity valve for surgical aortic
valve replacement
Alteration of Plasma Concentration of Trace Elements Selenium and Cobalt During and
After Coronary Artery Bypass Grafting Surgery
Endovascular treatment for traumatic aortic transection: 13 years experience of
a single center

1030-1100

Break

1100-1230

Best Abstracts Presentation
Chairpersons: Ngai-yin Chan, Suet-ting Lau
Judges: Chun-ho Cheng, Ngai-shing Mok, Bryan PY Yan
Prognostic Value of Hepatorenal Function by Modified Model for End-stage Liver
Disease (MELD) Score in Patients Undergoing Double Valve Replacement
Role of Adipocyte Fatty Acid-Binding Protein in LV remodeling and Diastolic
Function in Type 2 Diabetes: A Prospective Echocardiography Study
The prevalence and prognosis of tricuspid regurgitation in stage A to C heart failure
with preserved ejection fraction
Inhibition of IRE1 branch of ER Stress Ameliorates Myocardial Ischemia/Reperfusion
Injury via Inactivation of sEH and JNK/c-Jun pathway
Prolonged Valsartan Use And Cancer Risk
The Impact of Metabolic Syndrome on Air Pollution (PM2.5)-related Atherogenesis
in Modernizing China: A report from CATHAY Study

1230-1300

Lunch Break

1300-1500

Guidelines and Practice: Clinical Case Based Conference (GAP-CCBC) − Session 1
Chairpersons:

12

Tai-chung So
Jacky YK Ho
Derek KW Yau
Wen-tao Sun
Joyce Shek
Ka-lam Wong
Kevin Lim
Jia-yi Zhou
Jacky YK Ho

Yu-juan Yu
Mei-zhen Wu
Qing-wen Ren
Hong-mei Xue
Tak-hon Chan
Kam-sang Woo

Case Series: Volume-Controlled Revascularization in patients with AMI during Primary PCI
PCI
AMI
An 80-year lady, fever, anaemia for 2 months
80
2
Management of an acute myocardial infarction patient with much thrombus burden:
a case report
Successful retrieval of entrapped rotablator after failure of traditional method
Who is the murderer of the twins with acute myocardial infarction simultaneously?

Ji-Fang He

Proximal radial artery recanalization and left main coronary artery intervention through
distal radial artery route: A case report

Ren-Rong Wang

April 2020

Yan Wang
Chun-chih Chiu
Andrew YW Li
Ya-Lei Han
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1500-1700

Guidelines and Practice: Clinical Case Based Conference (GAP-CCBC)  Session 2
Chairpersons:
Complaint of chest pain with dyspnoea: difference patients with different diagnosis

Zheng Wang

Case report: Revascularization of CTO in LAD by Real-time IVUS guiding
Zhi-Yong Zhang
IVUS
CTO
Case Report of cardiac sarcoidosis  A silent killer behind Dilate Cardiomyopathy
Chang Tou
A case of acute myocardial infarction caused by coronary embolism in an elderly woman Yan-Fei Qiu
OCT-derived fractional flow reserve during on site coronary angiography
1700-1830

Li-wei Chen

Heart Team Symposium: A Case-based Approach
Chairpersons: Alex PW Lee, Michael KY Lee, Randolph HL Wong
Panelists: Daniel TL Chan, Ka-lung Chui, Shing-fung Chui, Vincent WS Ng
Heart team in actions: Managing complex TAVI procedures
TMVRepair toolbox: clip, chord, ring, or hybrid?
Transcatheter therapies for tricuspid regurgitation
Heart team's journey over the past decade: A mitral surgeon's perspective
Panel Discussion

Michael KY Lee
Simon CC Lam
Yat-yin Lam
Song Wan

Saturday, 4 July 2020
0830-1030

Atrial Fibrillation & Antithrombotic Symposium
Chairpersons: Kai-fat Tse, Thomas Tunggal
Antithrombotic treatment in coronary artery disease and peripheral artery disease:
latest update and clinical implication
Use of NOAC in vulnerable patients with atrial fibrillation
Strategy and optimized workflow for AF ablation
Device design dictates closure success  Watchman FLX and other new generation
LAAO devices

0900-1000

Hung-fat Tse
Song-wen Chen
Simon CC Lam

Heart Rhythm Symposium I: Minimizing fluoroscopy and optimizing outcomes
Chairpersons: Hau-kwong Chung, Ming-ho Wong
Use of 3D mapping system in CIED implantation
Use of intracardiac echocardiography in EP procedures

1030-1100

Break

1100-1230

Heart Rhythm Symposium II
Chairpersons: Jacky K Chan, Ngai-shing Mok
S-ICD: Can it be the first choice in prevention of sudden cardiac arrest?
Leadless cardiac pacing for patients with atrioventricular block
ECG interpretation and treatment options for PVC and VT

1230-1400

Dominick Angiolillo

Ngai-yin Chan
Mansour Razminia

Jo Jo SH Hai
Jo Jo SH Hai
Hui-nam Pak

Lunchtime Symposium: Paradigm Shift in Cardiology
Chairpersons: Vincent OH Kwok, Chris KY Wong
SGLT2 Inhibition: New addition to the anti-heart failure armamentarium
Individualizing antiplatelet therapy in patients with chronic coronary syndrome

1400-1415

Break

1415-1430

Opening Ceremony & Award Announcement
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Subodh Verma
Marc P. Bonaca
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1430-1500

Hong Kong Heart Foundation Lecture
Chairperson: Chu-pak Lau
Finding the silent danger: Who, when and how for AF screening?

1500-1530

Break

1530-1730

ESC@HKCC ASC: Echocardiography and Valvular Heart Disease
Chairpersons: Eric CY Wong, Li-wah Tam
How to assess tricuspid regurgitation in light of new prognostic information?
State-of-the-art 3D echocardiography for structural heart intervention
Imaging in atrial fibrillation
Low flow low gradient Aortic stenosis - challenges in diagnosis and management

1730-1900

Ngai-yin Chan

Jose Luis Zamorano
Alex PW Lee
Jeroen J. Bax
Eric CY Wong

Coronary Ischaemia Symposium
Chairpersons: Yu-ho Chan, Man-chun Choi, Kwok-lun Lee, Peter CY Wong
Update on the management of chronic stable angina
Can we stabilize and even regress the atherosclerotic plaque? Going beyond statin!
How to optimize PCI outcome?

Cheuk-man Yu
Peter J. Lansberg
Ho Lam

Sunday, 5 July 2020
0800-0915

KSC@HKCC ASC: Management of Coronary artery disease:
From cardiac imaging to coronary imaging and physiology
Chairpersons: Carmen WS Chan, Ping-tim Tsui
Coronary imaging and physiology
My collection of IVUS and OCT cases: Lessons to learn
Cardiac imaging

0915-1030

ACC@HKCC ASC: Hope and challenge in cardiovascular medicine
Chairpersons: Chun-ho Cheng, Yuk-kong Lau
Cardiac Care in Women: a US Perspective
Cardiovascular benefits of antidiabetic drugs  have we reached a conclusion?
Cardio-oncology in 2020  opportunities and challenges

1030-1100

Break

1100-1200

Heart Failure Symposium
Chairpersons: Gary SH Cheung, Godwin TC Leung
Reverse remodeling in heart failure  how can we achieve that?
Biomarkers in the treatment of heart failure

1200-1230

Break

1230-1330

Lunchtime Symposium
Chairperson: Kathy LF Lee
PCSK9 inhibition: How to apply in lipid management?

1330-1530

Dipti Itchhaporia
Bernard MY Cheung
Richard Kovacs

James Januzzi
James Januzzi

Hung-fat Tse

Best Challenging/Interesting Cardiac Intervention Cases Presentation
Chairperson: Shu-kin Li
Judges: Kam-tim Chan, William CK Chan, Stephen WL Lee
Left bundle branch pacing as a physiological pacing alternative to cardiac
resynchronization therapy in patients with heart failure and left bundle branch block
A Case of Percutaneous Mitral Valve Repair In Acute Mitral Regurgitation Following
Myocardial Infarction
Reperfusion Injury Prevention, A Volume-Controlled Reperfusion Method in Acute
Coronary Artery Occlusion

14

Bon-Kwon Koo
Ping-tim Tsui
Yeonyee E Yoon
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Kit Chan
Calvin Leung
Ji-fang He
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Strange bedfellows
Double patch post-infarction ventricular septal rupture repair with infarct exclusion
for inferoposterior myocardial infarction
The First Case of Impella RP use in Acute Right Ventricular Failure from Air Embolism
1530-1600

Break

1600-1800

Best HKCC-HKPHCA Challenging/Interesting Clinical Cardiology Cases Presentation
Chairperson: Ngai-yin Chan
Judges: Kam-tim Chan, Raymond CY Fung, Kin-lam Tsui
Massive pulmonary embolism successfully resuscitated by E-CPR and
percutaneous thrombectomy
Polymorphic Ventricular Tachycardia in a Patient with High Dose Methadone Use
Case report of successful peripheral VA ECMO in a patient with chronic type B
aortic dissection
First marginal heart transplantation utilizing organ care system in Asia
Another Simple Pericarditis?
A Case of the Novel Coronavirus (COVID-19)-induced Myocarditis and
Takotsubo Cardiomyopathy

1800-1810

Closing Remark & Award Announcement

Daniel HF Fong
Joyce WY Chan
Yaser Khalid

Shek-yin Au
Weng-chio Tam
Shek-yin Au
Ka-lam Wong
Yue-hin Tang
Yaser Khalid
Ngai-yin Chan

*The program is subject to change without prior notice.

Paediatric Cardiology Program
Saturday, 4 July 2020
0830-1025

Free Paper Session (Abstract & Interesting Cases presentation)
Award presentation
Assessor & Chairpersons: Robin HS Chen, Maria SH Lee
Judges: Eddie WY Cheung, Yiu-fai Cheung, Maurice P Leung, Sabrina SL Tsao
Clinical Application of Fetal Pulmonary Valvuloplasty for Pulmonary Atresia with
Intact Ventricular Septum with Worsening Right Ventricular Hypoplasia: Combined
with Postnatal Outcomes
Thrombocytopenia Associated with Transcatheter Closure of Giant Patent
Ductus Arteriosus
Attenuation of cardiomyocyte hypertrophy via depletion Myh7 using CASAAV
AAV gene therapy prevents and reverses heart failure in a murine knockout model of
Barth syndrome
Paediatric Myopericarditis - A Single Regional Hospital Experience
Pacing Therapy in Infants with Congenital Complete Heart Block in Hong Kong
Genetic Spectrum of Paediatric Cardiomyopathy in Hong Kong
Double balloon dilation of pulmonary arterial bifurcation stenosis after previous
surgical palliations: a case report
Life-threatening Flecainide Toxicity related to Alteration of Milk Feeding in an Infant
Successful resynchronization therapy for an infant with dilated cardiomyopathy

1025-1030

Welcome Address

1030-1130

Paediatric Cardiology Symposium I
Chairpersons: Grace KS Lam, Nai-chung Fong

Lei Liu
Pang Yue
Yi-fei Li
Ka-shing Chung
Sit-yee Kwok
Zhou Julia Shi
Shu-liang Xia
Zhou Julia Shi
Sit-yee Kwok
Tak-cheung Yung

Prevention and reduction of cardiotoxicity in childhood cancer therapy
Cardiac assessment and monitoring in Paediatric oncology patients and survivors
1130-1145

Si-lin Pan

Grace PY Tong
Yiu-fai Cheung

Break
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1145-1245

Cardiac magnetic resonance assessment in oncology patients
Management of cardiotoxicity in childhood cancer patients

1245-1400

Lunch Break

1400-1500

Paediatric Cardiology Symposium II
Chairpersons: Dennis TL Ku, Dora ML Wong
Extracorporeal life support in critical ill paediatric cancer patients
Heart transplantation in adult cancer survivors with end stage heart failure

Carmen WS Chan
Sit-yee Kwok

Robin HS Chen
Ka-lam Wong

1500-1515

Break

1515-1615

Interesting cases sharing and discussion - by oncologist
Interesting cases sharing and discussion - by cardiologist

Calvin PL Hoo
Julia Shi

1615-1620

Closing Remark

Dennis TL Ku
Kin-shing Lun

*The program is subject to change without prior notice

Allied Cardiovascular Health Professional Symposium
New "Tools and Toys" in Cardiac Catheterization Laboratory
Saturday, 4 July 2020
Session 1

Chairpersons: Jackie SL Kan, Chiu-sun Yue

1000-1025

His-Purkinjee System Pacing

Ho-chuen Yuen

1025-1050

Impella Nursing Care

Chung-on Mak

1050-1120

Break

Session 2

Chairpersons: Wing-yee Kwan, David KY Lo, Thomas KS Wong

1120-1145

Wound Care in Interventional Cardiology

Wing-si Wong

1145-1210

New Tools for Calcified Coronary Lesions Part I: Intravascular Shock Wave Lithotripsy

Frankie CC Tam

1210-1235

New Tools for Calcified Coronary Lesions Part II: Coronary Orbital Atherectomy
System

Shing-fung Chui

16
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Cardiology Course for Family Physicians and General Practitioners
Sunday, 5 July 2020
Preventive Cardiology: Expanding the Role of Primary Care Physician in Cardiology
Chairpersons: Chi-wo Chan, Nim-pong Kwong, Kin-keung Tsang
0900-0930

Beyond HbA1c: preventing cardiac and renal complications in diabetic patients

Subodh Verma

0930-1000

Emerging role of NOAC in the treatment of CAD & PAD

Frankie CC Tam

1000-1030

Peripheral arterial disease in primary care: reasons why you should care

Bryan PY Yan

1030-1100

Break
Cardiology Updates: What a Primary Care Physician Needs to Know in 2020
Chairpersons: Chun-leung Lau, Albert WS Leung, Yui-chi So

1100-1130

New era for heart failure management

Katherine YY Fan

1130-1200

Appropriate treatment of clinical and subclinical atrial fibrillation

Jacky K Chan

1200-1230

New concepts in the management of angina

Duncan HK Ho

1230-1400

Lunch Break
Cardiology Issues in Women & Paediatrics
Chairpersons: Ronnie HL Chan, Kin-Shing Lun

1400-1430

Pregnancy and cardiac disease

Pak-cheong Chow

1430-1500

Common Paediatric arrhythmia for primary care physician

Sabrina SL Tsao

1500-1530

Update on Paediatric Hypertension Guidelines

Nai-chung Fong

1530-1600

Break
Common Cardiology Challenges in Primary Care
Chairpersons: Alan KC Chan, Ho Lam

1600-1630

How to achieve maximally tolerated statin therapy for maximum protection

Bernard BL Wong

1630-1700

Strategies for better BP control and outcomes in hypertensive patients

Bernard MY Cheung

1700-1730

Managing heart failure and co-morbidities in primary care

Elaine MC Chau

*The program is subject to change without prior notice
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Risk of Ventricular Arrhythmia in Improved Left Ventricular
Ejection Fraction in Implantable Cardioverter-defibrillator for
Primary Prevention

Conclusion: In heart failure patients with ICD implanted as primary
prevention, the risk of VT/VF persisted even after improvement of LVEF to
>35%, the risk may be reduced but not eliminated.

TC So
Queen Elizabeth Hospital, Hong Kong
Background: About one-third of patients with ICD for primary prevention
had their LVEF improved to >35% in follow-up. The risk of ventricular
arrhythmia in this group of patients is unknown.
Methods: This is a retrospective, single centre study. Patients implanted
ICD/CRT-D for primary prevention from 2007-2018 were recruited, LVEF
were assessed by ECHO at least 1 year later. Patients were divided into 2
groups by their follow up LVEF, i.e. LVEF >35% or LVEF < or =35%.
Occurrence of VT/VF was defined by documented ventricular arrhythmia.
Primary outcome is the occurrence of VT/VF. Survival analysis was done
with Kaplan-Meier survival analysis and Cox proportional hazard model.
Results: 47 patients were included and 12 patients developed VT/VF in
follow up, accounting up to 25.5% of total patients. 23% (n=11) had the
LVEF improved to >35%, of which 9% (n=1) developed VT/VF. 77% (n=36)
had the LVEF < or = 35%, of which 30% (n=11) developed VT/VF. KaplanMeier survival analysis showed no significant difference in occurrence of
VT/VF (Log rank test, p=0.15). In the Cox model comparing patients with
improved LVEF to those with LVEF < or =35%, the hazard ratio was 0.28
(p=0.186) for occurrence of VT/VF.

53
Total Aortic Arch Replacement and Frozen Elephant Trunk:
Mid Term and Second Stage Surgery Outcomes
JYK Ho, SCY Chow, MWT Kwok, T Fujikawa, M Underwood, RHL Wong
Divsion of Cardiothoracic Surgery, Department of Surgery, Prince of Wales
Hospital, Hong Kong

Conclusion: We reported our mid term Thoraflex TAR FET with outcomes,
and the results from descending aortic pathologies second stage treatments.
Arterial cannulation site and time of antegrade cerebral protection were not
clinically reflected for risk of stroke or mortality. The observation of aortic
remodeling and dSINE requires further investigations.

Background: Aortic arch pathologies is a surgical challenge, involving
cerebral, visceral and myocardial protection. Total arch replacement
and frozen elephant trunk (TAR FET) had been evolved with promising
mid-term outcome in Europe. We evaluated our mid-term outcome on
TAR FET and the second staged descending aortic intervention.
Methods: Between August 2014 and April 2020, 41 patients with aortic arch
pathologies underwent TAR FET implant with Thoraflex-Hybrid-Plexus device
(Vascutek, Inchinnan, Scotland). Patients' perioperative, clinical and radiological
outcomes were reviewed.
Results: Post discharge survival (n=37) at 1 and 3 year were 100%. Overall
survival of 87.8% over a median follow up of 3.3 years, inpatient mortality of
9.7%. Distribution of aortic pathologies with acute Type A dissection or
intramural hematoma (n=15, 36.6%), thoracic aortic aneurysm, including arch
and descending aortic aneurysm (n=9, 22%) and chronic aortic dissection
including chronic type A and type B dissections (n=13, 31.7%). Mean operative,
circulatory arrest and antegrade cerebral perfusion time were 417±121 min,
89±28 min and 154±43 min respectively. Second stage procedures were
performed in 32% and distal stent graft induced new entry (dSINE) was
observed in 19% of patients.

18
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What Demographic Factors Influence Participation in a
Randomised Controlled Trial on Prehabilitation for Cardiac
Surgery?
DKW Yau,1,3 MJ Underwood,2 GM Joynt,1,3 A Lee1
1
Department of Anaesthesia and Intensive Care, The Chinese University of
Hong Kong; 2Division of Cardiothoracic Surgery, Department of Surgery, The
Chinese University of Hong Kong; 3Department of Anaesthesia and Intensive
Care, Prince of Wales Hospital, Hong Kong
Background: The ongoing PREQUEL study examines the effect of a
hospital-based physical prehabilitation program before cardiac surgery
to improve frailty and hence postoperative recovery. The objective of
this sub-study was to assess the association between baseline factors and
successful study participation.
Methods: This is a stratified RCT (ChiCTR1800016098) at a university
hospital in Hong Kong. 153 pre-frail and frail patients (Clinical Frailty
Scale [CFS] 4-6) who met the eligibility criteria were invited to participate
in the trial between July 2018 and March 2020. Non-participants were
defined as: inability to regularly attend, or indecisive/refusal to participate.
Mobility status was classified as good (independent outdoor walker) or
poor (homebound). Driving distance from home to hospital was estimated
using Google Maps software. Demographic and baseline clinical data
differences between participation groups were analysed using appropriate
univariate tests.

30
Effect of Homocysteine on the KCa Channel Family in Human
Internal Mammary Artery
WT Sun, HM Xue, HT Hou, HX Chen, J Wang, GW He, Q Yang
Center for Basic Medical Research & Department of Cardiovascular
Surgery, TEDA International Cardiovascular Hospital, Chinese Academy
of Medical Sciences & Peking Union Medical College, Tianjin, China
Background: We recently clarified the expression and distribution profile
of the calcium-activated potassium (KCa) channel family, including
large-, intermediate-, and small conductance KCa (BKCa, IKCa, SKCa)
subtypes in the grafts for coronary artery bypass surgery (CABG)
including internal mammary artery (IMA). This study further
investigated the effect of homocysteine, an independent risk factor for
atherosclerotic vascular disease, on the expression and functionality of
the KCa channel family in IMA.
Methods: Residual IMA segments were obtained from patients
undergoing CABG. The role of KCa subtypes in vasorelaxation and
vasoconstriction and the effect of homocysteine were studied in a wire
myograph. Western blot and immunohistochemistry were performed to
determine the effect of homocysteine on the expression and distribution
of KCa subtypes.

J HK Coll Cardiol, Vol 28

Results: There were 81 (52.9%) participants and 72 (47.1%) non-participants
during the 21-month period. Study participation groups were similar for mean
age (P=0.29), gender (P=0.58), occupation (P=0.27), education level
(P=0.84), living alone (P=0.44), regular exercise habits (P=0.24), types of surgery
(P=0.73), median frailty level (P=0.42), median left ventricular ejection fraction
(P=0.75) and median number of cardiovascular risk factors (P=0.11). Poor
mobility status was associated with the study participation, with no homebound
participants recruited into the study (P=0.047). Participation rates varied across
districts (33-100%), with 3 patients living across the border. For Hong Kongbased patients, study participants lived closer to the hospital than nonparticipants (n=150; median [IQR]: 21.8 km [7.5-32.0 km] vs 30.4 km [13.3-34.8
km]; P=0.02). Patients who lived ≤20 km of the hospital were more likely to
participate in RCT than those living >20 km away (RR: 1.49, 95% CI: 1.12-1.99).
Conclusion: Good mobility status and closer residential distance from the
hospital were associated with successful RCT participation. Recruitment
strategies that address ambulatory and transport difficulties may increase the
participation of patients living far away from the hospital.

Results: Blockade of the BKCa subtype significantly suppressed
acetylcholine-induced relaxation and enhanced U46619-induced
contraction. In comparison, blockade of IKCa or SKCa subtypes
individually or jointly barely affected the relaxation and contraction of
IMA. Homocysteine exposure compromised the vasodilating activity
of the BKCa subtype in IMA, evidenced by the suppressed relaxant
response to the BKCa channel opener and the diminished effect of the
BKCa channel blocker on acetylcholine-induced relaxation and U46619evoked contraction. The loss of BKCa channel function was associated
with a lowered protein level of BKCa β1 subunits in the smooth muscle of
IMA. Homocysteine potentiated the role of IKCa and SKCa subtypes in
mediating endothelium-dependent relaxation without affecting the expression
of these channels.
Conclusions: The BKCa subtype in the KCa channel family plays a
significant role in the regulation of the tone of the IMA. Homocysteine
causes loss of BKCa β1 subunits in the smooth muscle of IMA, resulting in
compromised vasodilating activity of the BKCa channel. IKCa and SKCa
subtypes are unessential for IMA vasoregulation, whereas the loss of BKCa
channel function in hyperhomocysteinemic condition enhances the role of
IKCa and SKCa subtypes in mediating endothelial dilator function. We suggest
that targeting BKCa channels may form a strategy to improve the postoperative
graft performance in CABG patients with hyperhomocysteinemia who receives
IMA grafting.

April 2020
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Influenza Activity and ST-segment Elevation Myocardial
Infarction Incidence in Hong Kong
J Shek, PT Tsui, TY Tsang, CY Fung, HC Yuen, NS Mok, NY Chan
Princess Margaret Hospital, Hong Kong
Background: Influenza or acute myocardial infarction (AMI) is seasonal
with usual upsurge in winter months. Influenza might be a trigger of
AMI. The outbreak of COVID-19 in China led to population wide
masking, practice of hand hygiene and social distancing in Hong Kong
starting from late January 2020.
Methods: Our study aimed to look at the relationship between influenza
activity and ST-segment elevation myocardial infarction (STEMI)
incidence as well as the epidemiological impact of universal infection
control measures. Patients with a diagnosis of acute STEMI from January
2014 to March 2020 were retrieved from the Hospital Authority Clinical
Data Analysis and Reporting System. We also downloaded data of
influenza activity and air pollution from Centre for Health Protection
and Environmental Protection Department respectively.

48
Long Term Survival of One Hundred Left Ventricular Assist
Device Recipients in Hong Kong
KL Wong,1 K Fan,1 C Ho,2 OJ Lee,2 T Au2
1
Grantham Hospital; 2Queen Mary Hospital, Hong Kong

Results: With few exceptions, the STEMI incidence per standardized month
basically mirrored the influenza activity from 2014 to 2020. During the winter
of 2014-15, 2015-16, 2017-18 and 2018-19, the number of STEMI cases went
up with the influenza activity. The rise in the number of STEMI cases in
December 2016 and January 2017 was not obvious mirroring the
inconspicuous rise in influenza activity of the same period. The surge of
influenza during the summer of 2015 and 2017 was not accompanied by an
increase in the number of STEMI cases. Influenza activity is a predictor of
STEMI incidence after adjusting for air pollution and time factors. We
observed an abbreviated peak and narrow base of the influenza activity
curve for the winter of 2019-20. The number of STEMI cases rose to 220 in
December 2019 but then dropped significantly from January to March 2020
mimicking the influenza activity curve.
Conclusion: Our observation agrees with the hypothesis of AMI
triggered by influenza infection and cold weather. Furthermore,
population wide infection control measures during the COVID-19
pandemic might have contained influenza activity and possibly
reduced the population risk of STEMI.

Conclusion: While heart transplantation remained gold standard treatment for
patients with advanced heart failure with good long-term outcome, the rapid
advancement in durable mechanical circulatory support also provides another
therapeutic option for patients with stage heart failure.

Background: Therapeutic options for end stage heart failure remained
limited and limited donor supply remained the Achilles heel for heart
transplantation. With advancement in technology, left ventricular assist
device (LVAD) had been increasingly used both as bridge to
transplantation, bridge to decision as well as destination therapy. We
aimed to review the long-term survival of one hundred LVAD recipients
in Hong Kong.
Method: All the 100 patients who received LVAD therapy since the start
of the LVAD program in 2010 until December 2019 were included.
Survival were analyzed by Kaplan Meier analysis and compared by
Log-rank test.
Results: During the study period a total of 100 patients received LVAD therapy
(84% Male, mean age 48.4 years old). There were 88 patients received LVAD as
bridge to transplantation (BTT) or bridge to candidacy (BTC) as initial strategy
and 25 had subsequent heart transplantation. The remaining 12 patients received
LVAD as destination therapy. Overall survival was 85.8%, 80.7% and 70.9% at
1-year, 2-year and 4-year respectively as compared to benchmark survival of
81%, 70% and 49% at 1-year, 2-year and 4-year respectively in the INTERMACS
registry. There was no significant difference in post-transplant survival between
recipients with and without prior durable LVAD.

20
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Early Clinical Experience with the Rapid Deployment Intuity
Valve for Surgical Aortic Valve Replacement
K Lim, SCY Chow, J Ho, RHL Wong
Prince of Wales Hospital, Hong Kong
Background: Sutureless or rapid deployment valves is an appealing
alternative to traditional sutured valves for complex open, redo and
minimally invasive operations, with the potential to reduce crossclamp
and cardiopulmonary bypass times.
Methods: The Edwards Intuity valve consists of a standard Perimount
Magna Ease pericardial valve mounted on a balloon-expandable stainless
steel skirt. After placing three guiding sutures through the sewing cuff
and proper seating of the valve at the annular plane, a ballon is inflated
to anchor the metallic frame at the left ventricular outflow tract.
A retrospective review was conducted on all consecutive patients
who received the Intuity valve at the Prince of Wales Hospital. Demographical,
clinical, echocardiographic and procedural data were extracted from the
Hospital Authority electronic patient records and analysed using SPSS 23.0.
Results: Eighteen valves in total were deployed at our institution from August
2018 to May 2020. The median duration of follow-up was 10 months.
Fourteen valves were implanted via median sternotomy, three via
hemisternotomy and one via right mini-thoracotomy. All deployments
were successful at the first attempt.

26
Alteration of Plasma Concentration of Trace Elements Selenium
and Cobalt During and After Coronary Artery Bypass Grafting
Surgery
JY Zhou, 1 HT Hou, 1 SF Wang, 2 J Wang, 1 Y Cheng, 1 XX Liu, 1 Q Yang, 1
GW He,1,3,4,5
1
Center for Basic Medical Research & Department of Cardiovascular Surgery,
TEDA International Cardiovascular Hospital, Chinese Academy of Medical
Sciences & Peking Union Medical College, Tianjin, China; 2Unit of Perfusion,
TEDA International Cardiovascular Hospital, Chinese Academy of Medical
Sciences & Peking Union Medical College, Tianijn, China; 3Department of
Cardiovascular Surgery, The First Affiliated Hospital, Zhejiang University,
Hangzhou, China; 4School of Pharmacy, Wannan Medical College, Wuhu,
China; 5Department of Surgery, Oregon Health and Science University,
Portland, USA

61% (n=11) of the cohort were male. The median age was 69, ranging from 58 to
85. All patients had severe aortic stenosis with preserved left ventricular
ejection fraction (over 50%). Two patients (11.1%) had true bicuspid valves.
22% patients (n=4) had concomitant CABG. Two had a concomitant ascending
aortic replacement and another two patients had a concomitant mitral valve
operation. One required root enlargement to fit the Intuity valve. One patient
underwent redo SAVR with the Intuity valve for paravalvular leak in the
explanted metallic valve.
One patient who underwent isolated SAVR died from multiorgan failure.
One required resternotomy for haemostasis. Crossclamp and bypass
times for SAVR via median sternotomy was 60.8±14.9 minutes and
99.7±29.4 minutes respectively.
Two patients required permanent pacemaker insertion due to complete
heart block.
In terms of haemodynamic performance, mean transvalvular gradient
was measured in fifteen patients and averaged 7.33±3.18 mmHg.
Paravalvular leak was absent or trivial in all but one patient. That patient
with moderate PVL had underlying Behçet's aortitis.
Conclusion: Implantation of the Edwards INTUITY Valve System is
safe, efficient and the results are highly reproducible even in challenging
scenarios.

rhythm, the patients were also grouped to postoperative atrial fibrillation
(POAF+) and sinus rhythm (POAF-).
Results: The concentration significantly decrease for Se at T2
(105.24±4.08 vs. 68.56±2.42 µg/L, P<0.001) and T3 (105.24±4.08 vs.
80.41±3.40 µg/L, P<0.001) and for Co at T4 (0.35±0.19 vs. 0.26±0.13 µg/
L, P<0.001) and T5 (0.35±0.19 vs. 0.23±0.11 µg/L, P<0.001). Five patients
developed POAF. However, there was no significant correlation
between POAF(+) and POAF(-) groups, probably due to small sample
size.
Conclusion: This study for the first time identified the alteration of plasma
concentration of Se and Co during and after CABG surgery. The findings
suggest that supplementation of Se before or during CABG and that of Co
after CABG may become necessary for patients undergoing CABG. Further
study is warranted to clarify the correlation of Se and Co and the
development of postoperative AF.

Purpose: Trace elements including selenium (Se) and cobalt (Co) have
been known to be essential in the human body and are involved in the
development of arteriosclerosis and coronary artery disease. The present
study was designed to investigate the effect of cardiopulmonary bypass
(CPB) and CABG surgery on the plasma Se and Co during and after CABG.
Methods: From December 2019 to January 2020, preoperative plasma
samples from isolated first-time CABG patients (N=20; 10 males and 10
females) were prospectively collected. The blood sample was collected at
five points: after anesthesia and before CPB (T1), 45 min after CPB (T2),
90 min after CPB (T3), postoperative day1 (T4), and day 4 (T5), respectively.
The upper plasma was used for study. After CABG, according to the heart
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Endovascular Treatment for Traumatic Aortic Transection:
13 Years Experience of a Single Center
JYK Ho,1 ICH Siu,1 SCY Chow,1 K Lim,1 MWT Kwok, 1 CM Chu, 2 S Yu,2
RHL Wong1
1
Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales
Hospital; 2Department of Imaging and Interventional Radiology, Prince of Wales
Hospital, Hong Kong

Conclusions: In our experience, TEVAR performed in emergency settings for
the multiple trauma cases with aortic transection brings acceptable outcome.
Long term evaluation would be needed to understand effect of the stent graft
and aortic remodelling with aortic traumatic injury.

Background: Acute traumatic aortic transection most commonly affects
the proximal descending aorta and carries high risk of rupture and
mortality. Open surgical repair of the ruptured segment of aorta is
associated with high operative risk. Endovascular treatment arises and
showed promising results as a safe alternative. Aim of this article is to
review our experience with endovascular approach for the treatment of
acute traumatic aortic transection.
Methods: Between April 2006 and November 2019, 12 patients presented
to our institute with a diagnosis of traumatic aortic transection. Whole
body Computed Tomography (CT) evaluation and thoracic endovascular
aortic repair (TEVAR) was performed in both elective and emergency
bases. Perioperative parameters were retrospectively reviewed and
analysed.
Results: The overall 30 days survival was 100% and 1 year survival of 87.5%,
there was no recorded procedural related neurological complications. All other
patients had a zone III transection and at least grade 3 aortic transection. There
was no stent graft failure, collapse, endoleak or distal migration were detected
at follow up CT Scans.
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Prognostic Value of Hepatorenal Function by Modified Model for
End-stage Liver Disease (MELD) Score in Patients Undergoing
Double Valve Replacement
Y Yu
The University of Hong Kong, Hong Kong
Background: The Model for End-stage Liver Disease excluding
international normalized ratio (MELD-XI) score and the modified MELD
score with albumin replacing international normalized ratio (MELDAlbumin) score, which reflect liver and renal function, have been
reported as predictors of adverse events in the liver and heart disease.
Nonetheless, their prognostic value in patients undergoing double valve
replacement has not been addressed.
Methods: A total of 210 patients who underwent double valve
replacement were evaluated. Baseline clinical characteristics, dugs,
laboratory, and echocardiography parameters were recorded. The
adverse outcome was defined as the occurrence of heart failure requiring
admission or all-cause mortality with data retrieved from the interhospital
computer medical system.

14
Role of Adipocyte Fatty Acid-Binding Protein in LV remodeling
and Diastolic Function in Type 2 Diabetes: A Prospective
Echocardiography Study
M Wu, Y Chen, Y Yu, Q Ren, S Lam, HF Tse, KH Yiu
The University of Hong Kong, Hong Kong
Background: Patients with type 2 diabetes mellitus (T2DM) are known
to be associated with increased left ventricular (LV) mass and diastolic
dysfunction. Nonetheless, the mechanism of this is uncertain and likely
multifactorial. Adipocyte fatty acid-binding protein (AFABP) is a
cytokine which is associated with adverse cardiovascular events.
However, the role of AFABP in adverse LV remodeling and diastolic
dysfunction is unknown. The aim of this study is to investigate the
relationship between AFABP and the longitudinal cardiac structural and
functional changes in patients with T2DM.
Methods: The study comprised of 176 asymptomatic T2DM patients
without history of macrovascular disease (age, 60±10 years; men,
53.4%). Circulating AFABP concentration at baseline was measured.
Patients were subsequently divided into 4 quartiles according to sexspecific AFABP cutoff. Detailed transthoracic echocardiography was
performed to all patients at baseline and follow-up.
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Results: In multivariable Cox Regression Analysis, both of the MELD-XI score
and MEDL-Albumin score were significantly associated with long-term adverse
events but not significantly associated with 1-year adverse events. MELD-XI
and MELD-Albumin scores were excellent predictors of 1-year adverse
outcome (area under the curve: 0.65 and 0.66, respectively) and long-term
adverse outcome (area under the curve: 0.61 and 0.68, respectively). KaplanMeier survival curve demonstrated that a high score on MELD-XI (≥10.94)
and MELD-Albumin (≥9.80) were significantly associated with an increased
risk of 1-year adverse events. During a median follow-up of 74 months, the
high score on MELD-XI (≥12.36) and MELD-Albumin (≥10.84) scores were
significantly associated with an increased risk of long-term adverse outcome,
even after adjusting for potential confounding factors. Smoking and atrial
fibrillation were associated with long-term adverse events, age is always
associated with postoperative adverse events.
Conclusions: Both the MELD-XI and MELD-Albumin score can provide
useful information to predict long-term adverse outcomes in patients
undergoing double valve replacement. The present study supports the
monitoring of modified MELD score to improve preoperative risk
stratification of these patients.

Results: The median duration between echocardiography assessment was 28
months. At baseline, AFABP was positively correlated with LV mass (R=0.19,
P<0.05) and E/e' ratio (R=0.27, P<0.01) and negatively correlated with e' septal
(R=-0.32, P<0.01) and e' lateral (R=-0.29, P<0.01). Nonetheless, AFABP was
not associated with LV ejection fraction (R=0.13, P=0.09). Compared with the
lowest AFABP quartile, the highest AFABP quartile had a higher LV mass at
baseline and follow-up (all P<0.01). Importantly, increase in LV mass was
significantly greater in patients with the highest AFABP quartile than those
with the lowest quartile (P<0.01). Further, worsening of E/e' was significantly
greater in the highest quartile than the other three quartiles (P<0.01).
Multivariable linear regression demonstrated baseline AFABP predicted
increase in LV mass (β=0.23, P<0.01) and worsening of E/e' (β=0.24,
P<0.01).
Conclusion: AFABP is independently associated with an increase in LV mass
and worsening of E/e' in asymptomatic T2DM patients. The present study
thus supports a contributing role of AFABP in the development of adverse LV
remodeling and diastolic dysfunction.
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The Prevalence and Prognosis of Tricuspid Regurgitation in
Stage A to C Heart Failure with Preserved Ejection Fraction
Q Ren, Y Chen, MZ Wu, YJ Yu, KH Yiu
The University of Hong Kong, Hong Kong

Conclusions: The presence of moderate/severe TR is not uncommon in
patients with stage A, B and C HFpEF. Importantly, moderate/severe TR
was independently associated with mortality and HF requiring
hospitalization.

Background: Previous studies have demonstrated that moderate/severe
tricuspid regurgitation (TR) is associated with adverse outcome in
patients with heart failure (HF) with reduced ejection fraction. However,
little is known about the prevalence and prognostic value of TR in
patients at risk of HF (stage A, B) and those with stage C heart failure
with preserved ejection fraction (HFpEF).
Methods: A total of 2882 patients with stage A (n=904), B (n=1305)
and C (n=673) HFpEF from 2013 to 2017 were enrolled. Detailed
transthoracic echocardiogram was performed and the severity of TR
was graded. Patients were prospectively follow-up at our heart failure
clinic.
Results: The age of the study population was 65 and 47% were male.
Hypertension was presence in 58% and diabetes in 33% and the mean left
ventricular ejection fraction was 62%. The prevalence of moderate/severe TR
increased from stage A to C HF (4.2%, 5.9% and 16.5%, respectively, P<0.01).
Older age, atrial fibrillation and higher HF stages were independently associated
with moderate/severe TR. Kaplan-Meier curve revealed that the presence of
moderate/severe degree of TR was associated with all-cause mortality and HF
requiring hospitalization (Log-rank test P<0.01). Multivariable analysis
demonstrated that moderate (hazard ratio=1.6, P<0.01) and severe TR (hazard
ratio=2.4, P<0.01) was independently associated with mortality and HF requiring
hospitalization.

25
Inhibition of IRE1 branch of ER Stress Ameliorates Myocardial
Ischemia/Reperfusion Injury via Inactivation of sEH and JNK/
c-Jun pathway
HM Xue,1,2 WT Sun,1 HT Hou,1 HX Chen,1 J Wang,1 GW He,1,3,4,5 Q Yang1
1
Center for Basic Medical Research & Department of Cardiovascular
Surgery, TEDA International Cardiovascular Hospital, Chinese Academy
of Medical Sciences & Peking Union Medical College, China;
2
Department of Physiology, Hebei Medical University, Shijiazhuang,
China; 3Department of Cardiovascular Surgery, The First Affiliated
Hospital, Zhejiang University, Hangzhou, China; 4School of Pharmacy,
Wannan Medical College, Wuhu, China; 5Department of Surgery, Oregon
Health and Science University, Portland, USA
Background: Studies of ischemia/reperfusion (I/R) reported the
respective role of endoplasmic reticulum (ER) stress and soluble epoxide
hydrolase (sEH) in myocardial injury. Whether there exists a link between
these two mechanisms remains unknown, which was investigated in the
present study with further exploration of the signaling molecules
involved in myocardial I/R injury.
Methods: Hearts isolated form male WKY rats were randomly allocated
to five groups: control, I/R, and I/R pretreated with IRE1α inhibitor GSK2850163,
JNK inhibitor SP600125, or sEH inhibitor dicyclohexylurea (DCU). The rat
hearts were mounted on a Langendorff apparatus and perfused with Krebs at
a constant pressure. The I/R groups were then subjected to 30-min global
ischemia followed by 60-min reperfusion. GSK2850163, SP600125, and DCU
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were perfused for 15 min prior to the onset of ischemia. Left ventricular function
was recorded and the left anterior descending artery was isolated after
reperfusion to study endothelial dilator function in a wire myograph. The
protein expression of phosphorylated IRE1 (p-IRE1), IRE1, JNK, c-Jun, and
sEH was determined by western blotting.
Results: Left ventricular end diastolic pressure (LVEDP) was increased
and the maximum velocity of contraction (+dp/dtmax) and relaxation
(-dp/dtmax) of the left ventricle were decreased during I/R, which could
be partially reversed by GSK2850163, SP600125, or DCU
preconditioning. Pretreatment with GSK2850163 SP600125, or DCU
also preserved the acetylcholine-induced coronary artery relaxation in
hearts subjected to I/R. Inhibition of IRE1 phosphorylation by
GSK2850163 significantly downregulated the protein expression of
JNK, c-Jun, and sEH.
Conclusion: The IRE1 branch of ER stress mediates cardiac and coronary
dysfunction in myocardial I/R through activation of sEH and JNK/cJun pathway.
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Prolonged Valsartan Use and Cancer Risk
TH Chan,1 MF Tsoi,1 BMY Cheung1,2,3
1
Department of Medicine, The University of Hong Kong; 2State Key Laboratory
of Pharmaceutical Biotechnology, The University of Hong Kong; 3Institute of
Cardiovascular Science and Medicine, The University of Hong Kong, Hong
Kong
Background: Generic valsartan suspected to be contaminated by
nitrosamines was recalled in Hong Kong in 2018. The study aimed to
investigate whether the prolonged use of valsartan is associated with
increased cancer risk.
Methods: Patients prescribed valsartan or amlodipine (control group)
from 1st January 2003 to 30th June 2009 were identified using the
Clinical Data Analysis and Reporting System of the Hong Kong Hospital
Authority. Patients previously diagnosed with cancer, prescribed both
medications, or taking the medication for less than a year before the
cancer diagnosis were excluded from analysis. Patients were followed
until a cancer outcome, loss to follow-up, or end of study period (31st
June 2019), whichever occurred first. Cancer incidence was the primary
outcome, and incidences of common cancer types were the secondary
outcomes. Results were analysed using R version 3.6.1. The incidence
rate, incidence rate ratio, and 95% confidence interval (CI) of cancers
were estimated using Poisson regression.

55
The Impact of Metabolic Syndrome on Air Pollution (PM2.5)related Atherogenesis in Modernizing China: A Report from
CATHAY Study
KS Woo,1 TCY Kwok,1 MK Wong,1 PY Chu,1 P Chook,1 YJ Hu,2 YH Yin,3
PW Lee,1 DS Celermajer4
1
The Chinese University of Hong Kong, Hong Kong; 2Nineth Peoples' Hospital
of Chongqing, China; 3Second Hospital of Chongqing Medical University,
China; 4The University of Sydney, Australia
Background: Air pollution (AP) and metabolic syndrome (MS) are
imminent global health hazard of the 21st century, in mainland China
in particular. AP has been associated with prevalence of cardiovascular
diseases, stroke and respiratory disorders.
Aim: To evaluate the impact of metabolic syndrome on AP-related
atherogenesis.
Subjects and methods: 1557 Han adults (mean age 47.2±11.8 years,
male 47%) in Hong Kong, Macau, Pun Yu, Yu County (coal mine in
Shanxi), and 3-Gorges (Yangtze River) were studied. Cardiovascular
risk profiles (smoking, body mass index BMI, waist circumference,
blood pressure SBP/DBP, LDL-cholesterol, triglycerides TG, and fasting
glucose) and metabolic syndrome (IDF criteria) were evaluated. PM2.5 (satellite
sensor modeling) and atherosclerosis surrogates brachial reactivity (FMD)
and carotid intima-media thickness (IMT) were measured. Multivariate linear
regression was performed.
Results: MS was diagnosed in 340 subject (21.8%). Their smoking status,
gender and PM2.5 were similar in MS cohort versus the cohort without MS,
but age, SBP, DBP, waist, LDL-C, TG, HDL-C and glucose were higher in MS
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Results: Among 5023 valsartan users and 3692 amlodipine users, 887 and 740
were diagnosed with cancers, respectively, with median follow-up periods of
10.97 and 12.12 years. The age and sex-adjusted incidences of cancer for
valsartan and amlodipine users were 168.67 (95% CI 157.92-180.01) per 10,000
person-years and 175.83 (95% CI 163.85-188.94) per 10,000 person-year,
respectively. The cancer incidence rate ratio of valsartan relative to amlodipine
was 0.938 (95% CI = 0.879-1.000). Incidence rate ratios of valsartan relative to
amlodipine were insignificant for breast (0.99, 95% CI 0.66-1.48), colorectal
(1.00, 95% CI 0.82-1.22), lung (0.92, 95% CI 0.73-1.66) and prostate cancers
(0.92, 95% CI 0.58-1.46).
Conclusion: Valsartan use was not associated with increased cancer incidence
when compared to amlodipine during a follow-up period of more than 10 years.

group. Brachial FMD is significantly lower (7.3±2.0% vs 8.1±2.65%) and carotid
IMT significantly higher (0.70±0.13 mm vs 0.63 mm±0.14 mm) in MS cohort
than MS negative cohort (P<0.0001).

PM2.5 (µg/m 3)
Age (yrs)
Male (%)
Smoking (%)
SBP (mmHg)
DBP (mmHg)
Waist (cm)
LDL-C (mmol/l)
TG (mmol/l)
HDL-C (mmol/l)
Glucose (mmol/l)
Brachial FMD (%)
Carotid IMT (mm)

MS Cohort
(N=340)

MS negative
Cohort
(N=1217)

P-Values
(Bonferroni
adjustment)

65.6±17.2
51.0±9.7
46.2
26.7
134.6±17.1
86.1±9.7
87.1±8.6
2.9±1.0
2.1±1.6
1.01±0.21
6.0±1.3
7.3±2.0
0.7±0.13

61.5±18.9
46.1±12.9
48.1
26.4
118.8±15.8
76.4±10.0
76.1±8.4
2.8±1.0
1.1±0.8
1.27±0.35
5.3±0.9
8.1±2.6
0.63±0.14

0.95
0.04
0.90
0.99
<0.001
<0.001
0.03
0.062
<0.001
<0.001
<0.001
<0.0001
<0.0001

On multivariate regression, PM2.5 was significantly related to carotid IMT in
both MS-negative cohort (beta=0.492, P<0.0001) and MS cohort (beta=0.285,
p<0.0001), independent of age, smoking, gender, LDL-C and locations. The
detrimental impact of PM2.5 was greater in subjects with no MS (R2=0.468,
F-value=131.6, P<0.0001), compared with MS subjects (R2=0.223, F-value=
14.8, P<0.0001).
Conclusion: Both AP and MS have independent impact on atherogenic process
in China, with implication in atherosclerosis prevention.
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Left Bundle Branch Pacing as a Physiological Pacing Alternative
to Cardiac Resynchronization Therapy in Patients with Heart
Failure and Left Bundle Branch Block
K Chan
Pro-care Heart Clinic, Hong Kong
Background: Cardiac synchronization (CRT) is indicated in patients
with left ventricular ejection fraction (LVEF) ≤35%, QRS ≥150 ms and
congestive heart failure (CHF) despite optimal medical therapy. However,
some patients with CRT indications could not benefit from the therapy
due to implantation failure or financial constraints. Even with successful
CRT implantation, the non-responder rate remains as high as 30%.
Case: We report a 70-year-old male patient who suffered from decompensated
CHF, first-degree atrioventricular block (AVB), left bundle branch block (LBBB)
and poor LVEF of 35%. He had junctional bradycardia with wide complex
escape. He had indication for CRT implant but he could not afford the procedure
due to financial reason.
Decision making: Left bundle branch pacing (LBBP) was peformed as a
physiological pacing alternative to CRT in this patient wiht CHF and cardiac
conduction disease.
Procedure description: The procedure was performed under local anesthesia.
Venous access was obtained by left subclavian puncture. The 4.1Fr Select
Secure 3830 active fixation lead was delivered into the right ventricle (RV) via
7Fr C315 fixed-curve delivery catheter. The His signal was mapped and

24
A Case of Percutaneous Mitral Valve Repair in Acute Mitral
Regurgitation Following Myocardial Infarction
C Leung
Queen Elizabeth Hospital, Hong Kong
Background: Acute mitral regurgitation in the setting of acute myocardial
infarction was associated with increase mortality and morbidity. The
mechanisms include papillary muscle rupture/dysfunction, or leaflet
tethering following sudden onset of regional or global left ventricular
dysfunction. This can lead to pulmonary edema or cardiogenic shock in
acute or subacute phase of myocardial infarction. Large scale clinical
data of MitraClip (Abbott Vascular) in this subset of patient is currently lacking.
Here, we presented a case of acute ischemic MR and pulmonary edema
following ST elevation MI. He was successfully managed with the MitraClip
device.
Case: A 77-year-old gentleman with PCI to LAD done in outside hospital
presented to us with chest pain and acute pulmonary edema. He
developed respiratory failure requiring mechanical ventilatory support.
Initial ECG revealed anterior ST elevation. Cath lab was activated and
primary PCI was performed. Angiography and OCT showed acute stent
thrombosis leading to LAD occlusion. He made initial recovery following
successful OCT guided PCI to LAD. However, he had subsequent rapidly
downhill clinical course with frank pulmonary edema and was reintubated. TEE showed impaired ejection fraction with regional wall
dysfunction, and severe acute ischemic MR due to restricted posterior leaflet
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identified using the Select Secure lead in unipolar mode. After identifying the
His location, the lead was advanced 1-2 cm more apically from the His location.
The optimal LBBP site was initially identified by searching for "W-shape"
morphology in V1 during RV pacing. The lead was then screwed into
interventricular septum (IVS). The optimal depth of lead implantation was
determined by QRS width and morphology in V1 during high/low-output pacing,
and serial impedance measurement. The lead was finally implanted at posterior
septal region close to left posterior fascicle area. During LBBP, the V1
morphology changed from LBBB pattern to rSR pattern. The QRS was
shortened from 150ms to 120ms. Echocardiogram 3 days after procedure
showed improvement of LVEF from 35% to 45%. The mitral
regurgitation (MR) severity was reduced and the diastolic MR was
eliminated during LBBP. The patient's CHF symptoms improved after
the procedure. He could tolerate beta-blocker therapy well after LBBP.
Conclusion: Left bundle branch pacing (LBBP) could be a viable
physiological pacing alternative to CRT in patients with heart failure
and CRT indications. Left bundle branch block could be elimiated by
LBBP. Improvement of LVEF and MR severity could be demonstrated
as short as 3 days after procedure.

motion. Repeated cardiac catheterization showed patent coronaries, giant CV
wave compatible with severe MR with significantly elevated LVEDP. He was
refractory to medical therapy and failed to wean off ventilator. Percutaneous
mitral valve repair was suggested after HEART team review. It was successfully
performed with the MitraClip device under TEE guidance. There was mild
residual MR post procedure with satisfactory hemodynamic improvements.
There was no serious complication. He was weaned off ventilator post
procedure. Clinically, he was out of heart failure with good functional recovery.
He was discharged with medical therapy. During his clinic visit at 1 month, he
was ambulatory NYHF class I.
Discussion: Percutaneous repair of acute MR in AMI is an emerging
alternative to surgery. It offered potential advantage of rapid decrease
of left atrial/pulmonary pressures and increase in cardiac output while
avoiding major operation in AMI setting. Good early outcome was
achieved in this particular patient with acute ischemic MR refractory to
medical therapy and favorable anatomic characteristics. Improvements
in echographic, hemodynamic and clinical parameters were
demonstrated.
Conclusion: In this case report of acute mitral regurgitation following
myocardial infarction, edge-to-edge mitral valve repair with the MitraClip
was successful with good early outcome. Further investigation in this
setting may be warranted.
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Reperfusion Injury Prevention, A Volume-Controlled Reperfusion
Method in Acute Coronary Artery Occlusion
J He
Heart Center, Chao-yang Hospital, Capital Medical University, Beijing,
China
Background: Ischemic reperfusion injury (IRI) prevention is a
challenging task during primary percutaneous catheterization
intervention . We report a case with modified ischemia postconditioning
(IPost) in an acute proximal occlusion of right coronary artery (RCA).
Case: A 54-year-old man diagnosed with acute inferior ST elevation
myocardial infarction for 6 hours, with prourokinase thrombolysis
failure, was ready for rescue percutaneous intervention. Angiography
demonstrated proximal total occlusion of RCA. Radial route 6F JR
guide catheter engaged. Heart rate drop to 40-50 bpm and blood pressure
drop to 70/50 mmHg seconds during wire1 manipulation. The 3.0x15
mm balloon was delivered to occlusion site and inflated to 8atm
immediately. Intravenous injection of Atropine 1mg, Dopamine 3 mg.
Heart rate was back to over 80 bpm, blood pressure is 110/70 mmHg.
While keeping NC balloon inflation, another 6F guide catheter engaged
to RCA via right femoral route, wire2 across the balloon to distal RCA,
aspiration catheter was positioned 10-15 mm advanced of NC balloon
via wire2; angiography via aspiration catheter to confirm distal part patency;
intra- aspiration catheter infusion of mixture solution (artery blood 10 ml+

33
Strange Bedfellows
DHF Fong
Princess Margaret Hospital, Hong Kong
Background: ST-elevation myocardial infarction (STEMI) with large
thrombus load is a big challenge to interventional cardiologists. This
case presents an unconventional method of tackling the problem.
Case: 58 years old female, with history of old stroke, hypertension,
aortic valve bioprosthesis for aortic valve stenosis, was admitted for
anterior STEMI with cardiogenic shock. Per protocol, she was sent to
the cath lab for emergency primary percutaneous coronary intervention.
Coronary angiogram of the right was unremarkable but damping of
pressure was noted upon engagement of the left coronary artery.
However, initial coronary angiogram only showed haziness of the left
main ostium with Thrombolysis In Myocardial Infarction (TIMI) flow
score of 3 in both arteries. The left anterior descending artery was then
wired with a sion wire and a non-selective angiogram was performed
which showed a large left main coronary artery (LMCA) ostium with a
huge thrombus. Intravascular ultrasound confirmed the presence of a
large thrombus causing 90% obstruction to the LMCA.
Decision making: As the patient was in cardiogenic shock, immediate
treatment of the LMCA thrombus was necessary. However, in the presence of
a huge thrombus, distal embolisation causing no reflow was a common and
potentially lethal complication. The large size of the LMCA was also a concern.
A decision was made to utilise a peripheral cover stent which would be big
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heparin NS 10 ml), 20 ml/min for 5 mins, adjust volume and speed according to
blood pressure and heart rate variation. Then, balloon deflated, perform
angiography when hemodynamic status was stable. Two overlapping drugeluting stents were deployed from mid to proximal RCA. TIMI III blood flow
was documented after post dilation with 3.5x12 mm balloon at 12-16 atm. Patient
was safe transferred to ICU with stable condition. Elevated ST-segment resolute
to base level. No lethal arrythmia or severe discomfort was documented.
Decision making: IPost proved to be effective in many early studies and
some small group studies, while neutral results in large randomized controlled
trial(RCT). IPost procedures mainly copied from ischemia precondition
procedures, there are several inherent defects of current IPost procedure in
attenuating IRI. based on our understanding of IPost and "Gradual
Reperfusion", we introduced "Volume-Controlled Revascularization, VCR".
Contemporaneous forward blood flow balloon inflation blocking at the
occlusion site and distal reperfusion via aspiration catheter. RCT is carried
out to prove effect on IRI.
Conclusion: Volume Controlled Revascularization method is feasible and safe
in this case, could be served as an effective method to attenuate IRI. Medicine
can be delivered to distal part of artery before IRI happened in pharmacological
postconditioning with this method.

enough and can potentially trap the thrombus, preventing distal embolisation.
The LAD wire was exchanged to a V18 (0.018") guidewire and a Begraft
peripheral stent 5x18 mm was successfully implanted at the ostium of the
LMCA. There was immediate resolution of the ST segment elevation and
improvement in the patient's hemodynamic state. The post-PCI angiogram
showed a patent LMCA with no distal embolisation and TIMI 3 flow in both
the LAD and LCx.
Patient was subsequently discharged from the hospital symptoms free. She
had a 6 months follow up angiogram which showed patent coronary arteries
with mild restenosis at the distal stent.
Conclusions: Acute STEMI with large thrombus burden is a challenging
problem to manage. IVUS is a quick and effective to help in assessing
and characterising the lesions when performing PCI. It is important to
know the various tools available to you and think outside of the box.
Peripheral cover stents is a viable treatment option when treating ostial
left main lesions.
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Double Patch Post-infarction Ventricular Septal Rupture Repair
with Infarct Exclusion for Inferoposterior Myocardial Infarction
JWY Chan, SCY Chow, WT Kwok, RHL Wong
Prince of Wales Hospital, Hong Kong
Background: Surgical repair of post-infarction ventricular septal rupture
(VSR) carries a high operative mortality up to 42.9% historically. We
present our technique of concomitant double patch septal repair and
ventricular restoration with infarct exclusion.
Case: A 73-year-old man had delayed presentation of posteroinferior
STEMI 10 days after onset. IABP was inserted for APO and cardiogenic
shock. Coronary angiogram showed triple vessels disease.
Echocardiogram confirmed a 2 cm inferoposterior VSR with significant
left to right shunt, a mid-inferior left ventricular wall pseudoaneurysm,
and LVEF of 40%. After initial stabilization, emergency repair was
performed.
Following cardiopulmonary bypass and cardioplegic arrest, CABG was
done to mLAD and D1. The heart was lifted cranially, exposing
inferoposterior wall LV pseudoaneurysm with in-sucking and thinning.
Infarctectomy was performed, and the 2x2 cm posterior VSR was
trimmed till areas of healthy myocardium, resulting in a 6x2 cm septal
defect. Septal double pericardial patch repair was performed by
parachuting the first 8x4 cm oval patch to the RV side with interrupted 3O
prolene, followed by a second patch on the LV side which was left long and
redundant for infarct exclusion. Ventriculotomy was closed with infarct

68
The First Case of Impella RP use in Acute Right Ventricular
Failure from Air Embolism
Y Khalid,1 N Dasu,1 K Dasu2
1
Rowan University; 2Syracuse University, USA
Background: Currently there is a paucity of data on Impella RP use in
rare causes of acute right ventricle (RV) failure. Current indications for
Impella RP are limited and further research, such as additional cases and
trials, is needed to expand the indications for Impella RP to generalized
isolated right ventricular failure. To our knowledge, there have been no
reports in the literature of RP impella use for RV failure due to air
embolism.
Case report: We report a case of a patient with acute RV failure due to air
embolism who recovered from the temporary use of Impella RP. The patient
underwent a minimally invasive mitral valve repair with a 32 mm Edwards
annuloplasty ring and left atrial appendage ligation. Shortly after the patient
became hypotensive and went into cardiac arrest secondary to ventricular
fibrillation. Appropriate ACLS protocol was initiated. A bedside transthoracic
echocardiogram revealed a significant amount of air within the right ventricle
consistent with air embolism. Due to hemodynamic instability from the air
embolism, air was aspirated from the right central internal jugular vein catheter.
A bedside transesophageal echocardiogram revealed significant dilation of
the right atrium and ventricle along with ejection fraction (EF) of 20-25%. The

28

exclusion technique with double folding of the second patch, reinforced with
two felt strips and additional 3-O sutures.
IABP was weaned on day 3. Echocardiogram on day 6 showed no
residual VSR or pseudoaneurysm, and improved LVEF of 61%.
Decision making: We describe a novel technique of double patch repair
of VSR with the LV side of patch extending to exclude both the septal
defect and ventriculotomy zone from high LV pressures. The septal
patch is applied with interrupted sutures instead of continuous so that in
case of suture cut-through of unhealthy septal tissue, the overall integrity
of the patch will still be maintained. Aggressive trimming of friable
infarcted septal tissue is preferred, so as provide a reliable repair. Double
patch sandwich repair provides a more competent repair than single
patch as it better sustains pressure from both right and left ventricles,
and provides structural support to the septal wall itself. By extending
the LV patch to cover the ventriculotomy/infarctectomy area as opposed
a separate patch for infarct exclusion, we reduce suture placement and
shortens operative time.
Conclusion: Double patch VSR repair with infarct exclusion technique
provides a robust repair that is promising in the treatment of postinfarction VSR.

patient then required vasopressors for hemodynamic support. Subsequently,
the decision was made, due to worsening hypotension despite vasopressor
support, to take the patient to the cardiac catheterization laboratory for
placement of an Impella RP. During the placement of the Impella RP, the patient
had refractory ventricular fibrillation and an electrical storm despite twenty
electrical cardioversions. The patient had pulse oximetry readings of 100% but
had right-sided jugular venous distention along with a cyanotic face and upper
extremities. Immediately after placement of the Impella RP, the patient's
ventricular fibrillation ended.
Decision making: We elected to proceed with Impella RP implantation because
the patient received all guideline-based treatment with volume expansion,
vasopressors, electrical cardioversions, and inotropic support, but remained
in refractory cardiogenic shock for RV failure secondary to air embolism.
Conclusion: Our case outlines both an extremely rare complication of air
embolism after minimally invasive mitral valve repair with hemodynamic
collapse, cardiac arrest due to ventricular fibrillation, and a novel use of the
Impella RP as salvage therapy. Further studies will be required to expand the
indications of the Impella RP. This case also illustrates that it is imperative for
clinicians to keep in mind rare causes of acute RV failure.
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Massive Pulmonary Embolism Successfully Resuscitated by
E-CPR and Percutaneous Thrombectomy
SY Au,1 SF Chui,2 KM Fong,1 KT Chan,2 MKY Lee2
1
Intensive Care Unit, Queen Elizabeth Hospital; 2Cardiology, Queen Elizabeth
Hospital, Hong Kong
Background: A patient with out-of-hospital cardiac arrest due to massive
pulmonary embolism was successfully managed by the cocktail of
extracorporeal resuscitation, percutaneous thrombectomy and systemic
heparin, in contrast to current guidelines' recommendations of prolonged
chest compression and thrombolytic.
Case: A 55-year-old obese man admitted for chest infection developed
central line associated left lower limb proximal deep vein thrombosis.
Despite full anticoagulation, he developed sudden cardiac arrest with
pulseless electrical activities. Echocardiography showed dilated and
pressure-overloaded right ventricle. The cardiopulmonary resuscitation
was refractory in 15 minutes' time and extracorporeal cardiopulmonary
resuscitation was started with total down time of 28 minutes. Percutaneous
pulmonary angiography was performed in the Cardiac Catheterization
laboratory as it provided better contrast enhancement as compared with
conventional computer tomography because the contrast was less drawn
by the ECMO circuit. Furthermore, ad-hoc percutaneous intervention
could be performed when the diagnosis of pulmonary embolism was
confirmed. The angiography confirmed bilateral massive main trunk
pulmonary embolism with no distal flow. Ad hoc thrombectomy was

51
Polymorphic Ventricular Tachycardia in a Patient with High Dose
Methadone Use
WC Tam, UP Lam, TM Mok, T Chang, W Ho, MA De Brito Lima Evora
Department of Cardiology, Centro Hospitalar Conde São Januário, Macao
SAR
Background: Methadone is usually used for the treatment of pain and
opioid addiction. This medication may be associated with acquired QT
prolongation and torsade de pointes (TdP).
Case: A 44-year-old female patient who presented herself with sudden
onset of impaired consciousness at emergency room. She was also a
methadone user for opioid addiction, receiving 130 mg/day. First 12
lead Electrocardiography revealed sinus rhythm with frequent PVCs.
Echocardiography revealed preserved left ventricle systolic function with mild
tricuspid regurgitation. The electrolytes level was within normal limit. However,
recurrent conscious disturbance was found about several minutes after first
episode. ECG monitor showed polymorphic PVCs, R on T, varying and twisting
QRS complexes around the baseline, suggestive of TdP with unstable
hemodynamic status. The ECG rhythm was converted to sinus rhythm by
herself after three times of 200J defibrillation. Repeated ECG showed sinus
rhythm with obvious QT prolongation (QT interval >600 milliseconds).
Decision making: We gave her lidocaine and magnesium sulfate to treat the
potentially fatal ventricular arrhythmia. After reviewing her medical history,
she denied any history of syncope or premature family history of sudden
death. Moreover, the previous ECG was documented 2 years ago which showed
sinus rhythm with normal QT interval. According to the prolonged QT interval
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performed and yielded large red clots. Despite residual clots, distal blood flow
was much improved after thrombectomy and further thrombus propagation
was prevented by systemic anticoagulation and auto-fibrinolysis. The ECMO
was decannulated in 3 days and the patient was extubated in 8 days. He
required life-long anticoagulation.
Decision making: The cocktail of veno-arterial ECMO (VA-ECMO),
percutaneous thrombectomy and systemic anticoagulation is beneficial
for patients who developed cardiac arrest after massive pulmonary
embolism. According to the European Society of Cardiology, the
recommended management includes prolonged chest compression of
60-90 minutes and for systemic thrombolytic during resuscitation.
However, thrombolytic is relatively contra-indicated after prolonged
resuscitation. The risk of surgical thrombectomy is again very high
especially with his deranged physiology and clotting profile immediately
post resuscitation. Meanwhile, massive pulmonary embolism is lethal
due to pulmonary shunting of blood, acute right heart failure and
obstructive shock, and such pathophysiology perfectly matches the
working mechanisms of VA-ECMO. With systemic anticoagulation and
auto-fibrinolysis facilitated by percutaneous thrombectomy to improve
distal pulmonary flow, the pulmonary emboli should resolve with time.
Conclusion: The cocktail treatment of extracorporeal resuscitation,
percutaneous thrombectomy and systemic heparin tackles well the lethal
mechanisms of massive pulmonary embolism while avoiding the potential
complications of thrombolytic in a patient with prolonged chest
compression.

and medical background of high dose methadone use, acquired Long
QT syndrome was suspected. Eventually, we discontinued methadone
and replaced it with benzodiazepine. Acute coronary syndrome was
excluded because coronary computed tomography showed insignificant
coronary artery disease with eccentric plaque over left anterior
descending artery. No recurrence of ventricular arrhythmia was noted
after discontinuation of methadone use. QT interval was shortened to
near 460 milliseconds before discharge.
Methadone may be associated with polymorphic ventricular tachycardia and
QT prolongation induced TdP. Methadone inhibits the Human Ether-a-go-go
related gene encoding for a potassium channel protein that regulates Ikr. This
Ikr blockage may cause prolonged duration of the phase III of the ventricular
action potential. Moreover, hypokalemia, hypomagnesemia, hypocalcemia,
concomitant use of psychiatric medication or anti-Human Immunodeficiency
Virus medication can also predispose the effect of QT prolongation from
methadone.
Conclusion: Methadone induced QT prolongation and TdP are rare but
serious events. Physicians should monitor the QT interval before and
during the methadone use, especially when high doses of methadone
are prescribed.
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Case Report of Successful Peripheral VA ECMO in a Patient
with Chronic Type B Aortic Dissection
SY Au, KM Fong, GWY Ng
Intensive Care Unit, Queen Elizabeth Hospital, Hong Kong
Background: Aortic dissection is in general considered a contraindication
for peripheral VA-ECMO. This is a case report of successful use of
peripheral VA-ECMO in a patient with aortic dissection bridging to
recovery, challenging the orthodox.
Case: A 53-year-old man with history of thoracic aortic arch aneurysm
and chronic type B aortic dissection from just distal to the left subclavian
artery to bilateral common iliac arteries, underwent an elective Bentall
operation. He developed low cardiac output state but the bypass could
be weaned off and the sternum was closed.
In 8 hours' time, he required escalating inotropes. Different mechanical
circulatory supports were contemplated: Intra-aortic balloon pump
(IABP) was contra-indicated in aortic dissection. Retrograde insertion
of Impella would be technically difficult and could traumatize the newly
implanted aortic graft and aortic valve. The patient was too ill to be
transferred for re-sternectomy to establish central VA-ECMO.
Percutaenous cannulation of the subclavian artery was technically
difficult especially in that emergency setting. We finally resorted to
peripheral VA-ECMO as a bail-out support.

47
First Marginal Heart Transplantation Utilizing Organ Care
System in Asia
KL Wong,1 OJ Lee,2 C Ho,2 K Fan,1 T Au2
1
Grantham Hospital; 2Queen Mary Hospital, Hong Kong
Background: Shortage of donor availability remained the Achilles heel
for heart transplantation. Significant proportion of donor hearts were
being declined due to single or more commonly multiple marginal
features. The organ care system (OCS) has been previously reported to
be safe and effective in accessing acceptability of marginal donor heart
without compromising post heart transplantation outcomes. In this report,
we described the first marginal heart transplantation utilizing OCS in
Asia.
Case: The recipient is a female 54 years old who has dilated
cardiomyopathy with biventricular failure and decompensation with
ventricular tachycardia. Echocardiogram revealed left ventricular
ejection fraction about 15% with severe clinical low cardiac output state
with poor appetite, nausea, vomiting, cold periphery and lactic acidosis
required double inotropic support for stablization. Cardiac catheterization
revealed normal coronary arteries with elevated mean right atrial pressure
17 mmHg, elevated pulmonary capillary wedge pressure 21 mmHg,
systemic pressure 95/57 mmHg, mean systemic pressure 70 mmHg, pulmonary
arterial pressure 33/19 mmHg, mean pulmonary arterial pressure 25 mmHg,
significant low cardiac output and cardiac index of 1.43 L/min and
1.03 L/min/m 2 despite inotropic support. Given her critical state with
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Decision making: Firstly, the pre-operative computer tomography scan was
reviewed to ensure that the major organs were all supplied by the true lumen,
as the fast retrograde blood flow will distend the true lumen while compressing
the false lumen. Secondly, real-time transesophageal echocardiography was
performed to guide the arterial cannulation. The true and the false lumen of the
dissection at the descending aorta were identified and the guidewire was
visualized when it was advanced retrogradely from the femoral artery. The
guidewire did accidentally go to the false lumen in the first 2 attempts and it
was redirected to the true lumen. The artery catheter was inserted by direct
visualization by re-opening the cut down femoral wound created during
bypass. Thirdly, in view of poor left ventricular function, preemptive left
ventricular venting was considered. As both IABP and Impella were
contraindicated, a catheter was inserted from right pulmonary vein to reach
the left ventricle through the left atrium for left ventricular venting.
He was given 12.5 mg of levosimendan infusion. In 5 days' time, the left
ventricular function improved and the patient could have his VA-ECMO
support terminated and subsequently discharged home.
Conclusion: With real time echocardiography guided cannulation, careful
review of the supply to the major organs and early planning of left
ventricular venting technique, peripheral VA-ECMO can still be
beneficial in aortic dissection.

biventricular failure, she has priority listing for heart transplant
waiting list. A heart transplant donor aged more than 55 with prior
history of smoking was available and coronary angiogram revealed
large dominant right coronary artery with 70% stenosis over distal
right coronary artery before bifurcation to large posterior descending
artery and large posterolateral branches.
Decision making: Given advance donor age with significant coronary artery
lesion, the graft would have been declined in the past. However, given urgency
of recipient, transplant team decided to proceed to use OCS for donor
management and assessment. The donor heart was successfully connected to
the OCS and cardiac contractility by direct visual assessment was good. Serial
lactic acid assessment of the graft showed good down trend and extraction of
lactic acid from the donor heart and thus the team decided to accept the graft.
Subsequent heart transplantation with coronary artery bypass grafting was
performed smoothly and the post-op recovery of the recipient was satisfactory.
Conclusion: This is the first successful marginal heart transplantation utilizing
organ care system in Asia. With the use of OCS, we aim to expand the availability
of suitable heart organs for transplantation.
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Another Simple Pericarditis?
YH Tang, TY Fung, NS Mok
Princess Margaret Hospital, Hong Kong
Background: A 19-year-old gentleman, with past history of sinusitis, aseptic
meningitis upon birth & subsequent epilepsy, came back from the UK
presenting with fever, sore throat, chills with myalgia, as well as pleuritic
chest pain.
Case: COVID-19 was ruled out. Despite appropriate medications, his
chest pain worsened together with epigastric pain. Fever persisted. Urgent
CT was arranged for him showing findings suspicious of pericarditis.
Serial ECG after admission revealed the classical findings compatible
with pericarditis. He was taken over to CCU with treatment for pericarditis
started.
Unfortunately, despite empirical broad spectrum antibiotics & antiinflammatories, his symptoms worsened with borderline blood pressure,
increasing tachypnoea & persistent fever. Blood tests showed sky high white
cell count up to 50 with neutrophil predominance.
Serial echocardiograms showed a gradual increase in posteriorly-loculated
pericardial effusion with fibrin, with striking findings of constriction
physiology. Significant respirophasic changes in mitral & tricuspid inflow
were demonstrated. Right-sided cardiac chambers were not collapsed, rather,
the RA & the IVC were dilated.
CT was repeated for deteriorating hemodynamics showing a rim-enhancing
pericardial effuision.

Decision making: In view of the constrictive physiology demonstrated
in echocardiograms, surgical intervention was deemed necessary for
the patient & he was sent immediately to Queen Elizabeth Hospital
Cardiothoracic Surgery team for emergency surgery.
Conclusion: The classical teaching of constrictive pericarditis describes
patients with prior insult to the pericardium such as surgery, previous
tuberculosis infection, prior radiotherapy exposure, etc, such that the
pericardium is calcified as a cage hindering the expansion of the heart.
However, with the presence of purulent and fibrin-rich effusion,
constrictive physiology can become evident and life-thereatening (Effusiveconstrictive pericarditis) as well.

67
A Case of the Novel Coronavirus (COVID-19)-induced
Myocarditis and Takotsubo Cardiomyopathy
Y Khalid,1 N Dasu,1 K Dasu2
Rowan University; 2Syracuse University, USA

1

Background: There is minimal data on the cardiac manifestations of
SARS-COV-2.
Case report: We present a patient with COVID-19 pneumonia complicated by
hypotension and cytokine storm, followed by viral myocarditis and takotsubo
cardiomyopathy.
Discussion: Rapid improvement of cardiac function after treatment
highlights the importance of obtaining early cardiac biomarkers and
non-invasive imaging in this population.
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Clinical Application of Fetal Pulmonary Valvuloplasty for
Fulmonary Atresia with Intact Ventricular Septum with
Worsening Right Ventricular Hypoplasia: Combined with
Postnatal Outcomes
S Pan
Qingdao Women and Children's Hospital, Qingdao, China
Background: Fetal pulmonary valvuloplasty (FPV) may inhibit
progression of pulmonary atresia (PA) or critical pulmonary stenosis
(CPS) in early and middle phases of pregnancy to hypoplastic right
heart syndrome (HRHS).
Methods: FPV was operated using a prediction score for a nonbiventricular outcome and a series of characteristics of fetal
echocardiography (Echo). We evaluate postnatal outcomes in 13 fetuses
with PA with intact ventricular septum (IVS) (n=10) or critical pulmonary
stenosis (CPS) (n=3) between July 2018 and June 2019. Live born
infants after FPV were followed up for at least 6 months to summarize
the indications of FPV.
Results: Median single ventricular outcome prediction score was two scores
(1 score to 4 scores) with an obvious reduction of the right ventricle. All fetal
Echo showed complete reverse flow of ductus arteriosus and massive tricuspid
regurgitation (3.50 to 4.22 m/s). All fetuses were observed for at least 2 weeks
before FPV to determine RV development stagnation. 3/13 fetuses were selected
to termination of pregnancy due to heart failure or RV dependent coronary
artery circulation (RVDCC) after FPV. 10/13 live births after birth. The median

39
Thrombocytopenia Associated with Transcatheter Closure of
Giant Patent Ductus Arteriosus
Y Li
West China Second University Hospital, Sichuan University, China

follow-up was 11.5 months (6 months to 17 months). 6/10 cases received
percutaneous pulmonary valvuloplasty (PBPV) and PDA stentting at the same
period. Four of them have achieved biventricular circulation, two still have an
undetermined circulation. 3/10 patients were treated with PBPV alone and one
case without any intervention. Of 10 live births of FPV fetuses, the currently
confirmed proportion of biventricular circulation is 70%.
Conclusions: Presently, we use a prediction score for a non-biventricular
outcome and Echo indications to screen right fetuses receiving FPV
preliminarily. In selected fetuses with PA/IVS or CPS in-utero, FPV
helps to promote the true development of the RV by reduced afterload
and increased filling. Thus improving the chances for a biventricular
outcome.

Conclusion: Once the the ratio of occluder size and body weight is greater
than 1.6, thrombocytopenia would always existed. While every unit of the
ratio of occluder size and body weight represents almost extra 3 days
hospitalization. Treatment would not reduce the hospitalization duration.

Introduction: Thrombocytopenia occasionally occurred following
closure of some giant patent ductus arteriosus cases. Unfortunately,
there is no associated research describing the associated risk factors of
thrombocytopenia post-procedure.
Methods: We reviewed all patients received occluder with size ≥10/12 mm
between January 2013 and June 2019. All the data and information on
characteristics of patients and their follow-up has been recorded. Univariate
analysis, receiver operating characteristic curves and linear regression have
been used to analysis the risk factor of thrombocytopenia and predictors for
hospitalization stay.
Results: Finally, 32 patients (17.5%) suffered thrombocytopenia.
Univariate analysis revealed the ration between occluder disc size (mm)
and body weight (Kg) (1.71±0.51 Vs. 1.35±0.53) as an independent
predictive factor for thrombocytopenia, and the area under the curve of
the ratio of occluder size and body weight for predicting
thrombocytopenia post-closure was 0.691 (95% confidence interval:
0.589-0.792, P=0.001). The best cut-off value for the ratio of occluder
size and weight as 1.5895 with sensitivity and specificity as 68.8% and
66.9%, respectively. The each unit of the ratio of occluder size and
body weight predicted an average hospitalization stay as 2.856 days
(95% confidence interval: 1.380-4.332). Medication treatment would
not reduce the hospitalization stay and benefit the restore of platelet.
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Attenuation of Cardiomyocyte Hypertrophy via Depletion Myh7
using CASAAV
Y Li, P Yue
West China Second University Hospital, Sichuan University, China

Conclusion: Myh7 still have a role both in maturation period, but observed an
rarely function in adulthood phases, which identified the therapeutic time
which should exceeded the period of maturation. Myh7 has been confirmed as
a potential therapeutic target, and the inhibition of Myh7 could help to reverse
CM hypertrophy.

Introduction: Myh7 is a potential target to attenuate cardiomyocyte
(CM) hypertrophy. Herein, we conducted this study to answer whether
the removal of Myh7 after birth would affect the CM maturation and
contribute to reverse pathological hypertrophy phenotypes.
Methods: CASAAV technique has been used in this research to deplete
the Myh6 and Myh7. While an AAV dosage of 5x109 vg/g was used to
generate a mosaic CM depletion model to explore the function of Myh7
in adulthood. CM hypertrophy model was induced by transverse aortic
constriction (TAC) at P28 of Rosa26Cas9-P2A-GFP mice. The heart
function was measured by echocardiography. Isolated CMs and in situ
imaging were used to analyses the structure and morphology of CM.
Results: CASAAV successfully silenced Myh6 and Myh7 in CMs. The
early depletion of Myh7 lead to an adulthood lethality. However, the
Myh7 P28-KO mice revealed a normal heart phenotype and function
and demonstrating a normal cellular size and the organization of
sarcomeres and T-Tubule. TAC mice also received AAV-Myh7-Cre to
produce Myh7 KO CMs which revealed a comparable normal CMs size,
while the echocardiography demonstrated a reverse of cardiac
hypertrophy.

42
AAV Gene Therapy Prevents and Reverses Heart Failure in a
Murine Knockout Model of Barth Syndrome
Y Li,1 S Wang,2 W Pu2
1
West China Second University Hospital, Sichuan University, China;
2
Boston Children's Hospital, USA

transduction (~70%) to be durable and effective. Altogether, we characterized
mammalian BTHS models that recapitulate many of the disease's clinical
features, and we used the models to demonstrate that AAV-mediated gene
replacement is efficacious when a sufficient fraction of CMs are transduced.

Barth syndrome (BTHS) is a rare X-linked cardiac and skeletal myopathy
caused by mutation of the gene Tafazzin (TAZ). Currently there is no
targeted treatment for BTHS and the understanding of disease pathology
and underlying mechanism has been hindered by lack of a proper
genetic animal model that recapitulates the features of BTHS. Here we
characterized murine germline (TAZ-KO) and cardiac specific (TAZCKO) Taz knockout models. TAZ-KO caused embryonic and neonatal
lethality, impaired growth, dilated cardiomyopathy, and skeletal
myopathy. TAZ-KO mice that survived the neonatal period developed
progressive, severe cardiac dysfunction and fibrosis. Cardiomyocyte specific
inactivation of floxed Taz in CMs using Myh6-Cre did not cause fetal or
perinatal loss, but caused progressive dilated cardiomyopathy. Using both
constitutive and conditional knockout models, we tested the efficacy and
durability of Taz replacement by AAV gene therapy. Neonatal AAV-hTAZ, in
which the CAG promoter drives full length human TAZ, rescued neonatal
death, cardiac dysfunction, and fibrosis in TAZ-KO mice, and both prevented
and reversed established cardiac dysfunction in TAZ-KO and TAZ-CKO
models. However, both neonatal and adult therapies required high CM
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Paediatric Myopericarditis - A Single Regional Hospital Experience
KS Chung, AWM Choi, WY Mak, NC Fong
Princess of Margaret Hospital, Hong Kong
Background: To study the clinical course, etiology and prognosis of
acute myopericarditis of children in a regional hospital over a period of
20 years.
Methods: Acute myopericarditis is defined as patients with chest pain,
diffuse electrocardiographic ST and T wave changes, elevated cardiac
markers such as troponin & CK-MB, and normal left ventricular systolic
function. A retrospective study of patients with diagnosis of acute
pericarditis/myopericarditis admitted during the period of 2000-2019
was done through Clinical Management System (CMS) of Hospital
Authority. Demographic data, symptoms, physical findings,
investigations, treatment, length of stay and outcome were reviewed.
Results: 29 patients were identified with male to female of 28:1. The
mean age was 14.4 yr (6.1-17.2). All of them presented with acute onset
of non-exertional retrosternal/left side chest pain, 2 of them also had
back pain. 9 and 5 of them had concomitant upper respiratory tract
symptoms and gastroenteritis respectively. However all viral study was
negative except 2 patients had their nasopharyngeal aspirate yielded rhinovirus/
enterovirus and influenza A. Autoimmune and toxicological screening were
unremarkable. Hemodynamics was stable with no pericardial rub detected.
Concave upward ST elevation was commonly found over inferior leads and

57
Pacing Therapy in Infants with Congenital Complete Heart Block
in Hong Kong
SY Kwok,1 NL Ho,1 KS Lun,1 TWK Au,2 R Barnabe,2 N Yam,2 S Tsao,1 TC Yung1
Department of Paediatric Cardiology, Queen Mary Hospital; 2Department of
Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong SAR

1

Background: Data in pacing therapy in infants with congenital complete
heart block are limited. We report our experience in the single tertiary
centre in Hong Kong.
Methods: All infants diagnosed with congenital complete heart block
and aged < 1 year at pacemaker implantation from 2006 to 2018 were
included. The clinical course was reviewed and changes in left ventricular
dimension were analysed. Device complication was recorded.
Results: Eight infants were recruited, with a median FU duration of 77.3
months (IQR 35.8-136.2). Two infants (25%) had evidence of low
cardiac output, while the rest of them were indicated for pacing therapy
either because of asymptomatic extreme bradycardia or wide escape rhythm.
The mean age of first pacemaker implantation was 9.9 days (range 1-38), with a
mean escape ventricular rate of 53.8 +/- 6.2 bpm and QRS duration of 76.3 +/27.8 milliseconds (ms). Epicardial dual-chamber pacing system was implanted
for all our infants. Two out of three infants with RV pacing developed RV
pacing induced LV dyssynchrony with ventricular failure at 3 and 6 months,
and ventricular function improved after the upgrade to biventricular pacing.
All patients with LV basal pacing (2/2) developed ventricular dysfunction at 8
and 9 month, with improvement after reducing pacing rate. In contrast, all
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V4-V6. There was no arrhythmia or deep Q wave found. The mean peak
CK-MB and hs-troponin I were 794 U/L (97-3012 U/L) and 7605 ng/L (3.1839600 ng/L) respectively. Echocardiographic study showed normal cardiac
contractility in all patients. 8 patients had echogenic pericardium, 3 patients
had a thin rim of pericardial effusion and 1 with mild mitral regurgitation.
Twenty-three patients were treated with NSAID for chest pain; 25 out of 29
patients had improvement of chest pain within 1 day. The mean length of
stay was 4.3 days (2-9 days). Two patients had CT coronary angiogram
done for slow decline of troponin and persistent mild chest discomfort,
and both was normal. There was no correlation of peak troponin I
level and duration of chest pain and outcome. The mean follow up
time was 370 days. All patients had a benign course with uneventful
recovery.
Conclusions: Paediatric myopericarditis is mostly a benign clinical entity
with good prognosis. Troponin level is not related to outcome as long
as there is no cardiac dysfunction and arrhythmia.

patients with LV apical pacing (2/2) did not develop heart failure. Three patients
had complication of epicardial lead fracture, at a median age of 108 months
(range 45-129). The z-scores of left ventricular end-diastolic diameter over
time were shown in graph. It demonstrated a trend of normalization of left
ventricular dimension over time.
Conclusion: Five out of eight infants (62.5%) with congenital heart
block developed subsequent ventricular dysfunction. LV apex appeared
to be the most favourable pacing site.
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Genetic Spectrum of Paediatric Cardiomyopathy in Hong Kong
ZJ Shi,1 JFT Chau,2 SY Kwok,1 KS Yeung,2 JLF Fung,2 TC Yung,1 BHY Chung,2
KS Lun1
1
Department Of Paediatric Cardiology, Queen Mary Hospital; 2Department of
Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The
University of Hong Kong, Hong Kong

Conclusion: Our study highlights the substantial diagnostic yield of genetic
evaluation in paediatric patients with cardiomyopathy. Since the genetic cause
of paediatric cardiomyopathy is heterogeneous, we believe exome sequencing
offers better coverage for pathogenic variants in this group of patients. The
genetic diagnosis is useful in clinical management and family counselling.

Background: Primary cardiomyopathies are rare conditions among the
paediatric age group with the incidence rate of 1 in 100,000 children.
Albeit being widely known as genetically-determined diseases, limited
studies have reported the prevalence and distribution of disease-causing
mutations in children, especially in Asian. In this study, we evaluated
the genetic spectrum of paediatric cardiomyopathy in a cohort of 50
patients, who were followed in our paediatric cardiology clinic in the
past 15 years.
Methods: Paediatric patients with cardiomyopathy were assessed by
cardiologists and clinical geneticist. Gene panel, exome sequencing and
chromosomal microarray were offered to patients based on their clinical
features. Variants were classified according to the American College of
Medical Genetics and Genomics (ACMG) guidelines.
Results: In this study, 40% patients (20/50) were diagnosed genetically. Among
these patients, eight (40%) were diagnosed with Noonan syndrome (BRAF,
PTPN11 and RAF1), seven (35%) were diagnosed with syndromic conditions
other than Noonan syndrome (DMPK, GAA, LAMP2, NONO, TAZ and 7q11.
23 deletion), and five (25%) harbored mutations in known genes associated
with primary cardiomyopathy (BAG3, MYBPC3, MYH7, MYL2 and TNNT2).
In addition, 18% (9/50) carried a variant of uncertain significance.

3
Double Balloon Dilation of Pulmonary Arterial Bifurcation
Stenosis after Previous Surgical Palliations: A Case Report
X Zhang, SL Xia, JB Li, YB Liu, X Zhang, XX Chen
Heart Center, Guangzhou Women and Children's Medical Center, Guangzhou,
China
Background: A five-year-old boy was presented to our center as postoperative
main pulmonary arterial bifurcation stenosis whose primary diagnosis was
pulmonary atresia/ventricular septal defect/major aorto-pulmonary collateral
arteries. First-stage palliation of modified Blalock-Taussig shunting was
performed on September 18, 2014. Second-stage RVOT reconstruction (with
valved conduit from bovine jugular vein)/ pulmonary arterial unifocalization/
partial repair of ventricular septal defect was performed in our center on July
27, 2017.
Case: Serial follow-up echocardiographies after operations demonstrated
stenosis at the anastomosis of the conduit and the bifurcation of main pulmonary
artery (PA). Cardiac catheterization on September 4, 2019 shows the internal
diameter of stenotic site was 7.6 mm, the diameter of proximal PA (conduit) was
14.8 mm, the proximal diameter of left PA and right PA was 8.2 mm, 9.7 mm,
respectively. The main-to-left PA pressure gradient was 40 mmHg, and the
main-to-right PA pressure gradient was 41 mmHg. After cardiac catheterization,
the bilateral femoral veins were accessed. Two 10 mm x 20 mm BALT balloon
catheters were sent to cross the stenosis with distal part in the LPA and RPA,
respectively. Then simultaneous dilation of two balloons with maximum
pressure of 12 atm was performed for 3 times. After dilatation, the stenosis
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was relieved. The final internal diameter of anastomosis was 12.1 mm, the
diameter of proximal end was 15.2 mm, the diameter of left and right pulmonary
artery was 9.5 mm, the pressure gradients of main-to-left and main-to-right PA
were 13 and 17 mmHg, respectively.
Decision making: The diameter and the pressure gradient across the stenosis
were consistent with the indications for invasive intervention. The patient
was at high risk for repeated surgeries, so transcatheter solution was the first
choice. Our plan is balloon angioplasty first, then stenting if balloon could not
work. Since branch PAs are rather small compared with main PA, single balloon
could not stand stably during dilation. So we used double balloon technique.
The size of single balloon was determined slightly larger than branch PAs.
And they turn out to fit the main PA [0.7 (≈√0.5) times the diameter].
Conclusion: Balloon angioplasty is feasible for anastomotic PA stenosis after
initial surgical palliation. Double balloon technique is a better choice for
bifurcation lesion with more safety.
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Life-threatening Flecainide Toxicity related to Alteration of Milk
Feeding in an Infant
Z Shi, SY Kwok, PC Chow, KS Lun, TC Yung
Department of Paediatric Cardiology, Queen Mary Hospital, Hong Kong
Background: Flecainide is a common drug of choice for management of
childhood tachyarrhythmias. It is also considered to be a narrow therapeutic
index drug.
Case: A 6-month-old boy with known atrial tachycardia was hospitalized for
three days of gastroenteritis symptoms and reduced milk feeding. Before and
during admission, he was on Nadolol, Amiodarone and Flecainide. ECG on
admission showed sinus rhythm at 107 bpm with normal PR interval, QRS
duration and QTc interval.
36 hours after admission, he developed acute decompensation with bradycardia,
hypotension and poor perfusion. There was significant metabolic acidosis
with base deficit of 14 mmol/L. Repeated 12-lead ECG showed isorhythmic
atrioventricular dissociation and wide complex ventricular escape rhythm at
49 bpm with right bundle branch block pattern.
He was immediately given fluid resuscitation, sodium bicarbonate infusion
and high dose inotropic support. All antiarrhythmic agents were discontinued.
Over the following 24 hours, we managed to gradually wean off all inotropes.
ECG was normalized after 30 hours. Serum flecainide level taken at the time of
acute deterioration was 1.44 mcg/ml (reference: 0.2-1.0 mcg/ml), confirming
flecainide toxicity.

63
Successful Resynchronization Therapy for an Infant with Dilated
Cardiomyopathy
SY Kwok,1 S Tsao,1 TC Yung,1 NL Ho,1 N Yam,2 YF Cheung,1 KS Lun1
1
Department of Paediatric Cardiology, Queen Mary Hospital; 2Department of
Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong

Decision Making: Adverse cardiac effects of Flecainide include negative
inotropic action, bradycardia or ventricular tachyarrhythmia, and depression
of all major conduction pathways, with typical ECG features of prolongation
of PR interval, QRS duration and QTc interval as in our case. Cardiac adverse
effects begins to rise at a plasma level of approximately 0.75 mcg/mL and
reaches 50% at 1.5 mcg/mL. Increased drug absorption associated with
stopping milk feeding had been reported in infants. The long half-life of
flecainide (averages 20 hours) may explain the delayed presentation of flecainide
toxicity in this infant. CYP2D6 genetic polymorphism and renal dysfunction
are other causes of altering Flecainide metabolism and clearance, although
these are not demonstrated in our patient.
Conclusion: Flecainide toxicity is life-threatening and its pharmacokinetics is
inadvertently related to milk intake. Close clinical and cardiac monitoring, or
pre-emptive medication adjustment should be contemplated if an infant's milk
feeding is significantly altered.

and left ventricular function. 14-month post-CRT implantation showed LVIDD
reduced to 2.4 cm and LVEF of 50-54%. NT-proBNP was 876 pg/ml.
Conclusion: A subgroup of DCM infant can be benefited from CRT, with
appropriate selection using ECG and advanced echocardiography.

Background: Resynchronization therapy for infants with dilated
cardiomyopathy is rarely used, with no guideline in patient selection.
Case: A 4-month-old infant presented with respiratory distress and
cardiomegaly. Echocardiogram found grossly dilated left ventricle with severely
impaired contraction. The left ventricular ejection fraction was 13% (LVIDD
5.0 cm). NT-pro BNP was 13,700 pg/ml. Secondary causes were ruled out and
anti-heart failure medication was commenced. However, she was readmitted to
hospital a month later because of poor feeding and exacerbation of heart
failure symptoms.
Decision making: Anti-heart failure medication had been maximized and there
was no clinical or echocardiographic improvement. Electrocardiogram showed
classical left bundle branch pattern. The QRS duration was slightly wide at
120 ms. Left ventricle strain assessment demonstrated ventricular
dyssynchrony. Basal anteroseptal myocardium showed earlier contraction
than posterolateral counterparts, with pre-stretching at early systole. CRT
therapy was thus recommended at her age of 6 month, with implantation of
epicardial dual chamber biventricular pacing system. QRS duration was
shortened to 98 ms and there was marked improvement in her clinical symptoms
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Meta-analysis of the Incidence of Infections in Clinical Trials
Randomizing Patients to Ticagrelor or Clopidogrel
HL Li, MF Tsoi, Y Fei, Q Feng, BMY Cheung
Department of Medicine, The University of Hong Kong, Queen Mary
Hospital, Hong Kong
Background: Ticagrelor is a platelet adenosine diphosphate P2Y12
receptor inhibitor. Recently, it was shown to have antibacterial activity
in vitro against Gram-positive bacteria including methicillin-resistant
Staphylococcus aureus (Lancellotti et al. JAMA Cardiol 2019;4:596-9).
In the Platelet Inhibition and Patient Outcomes (PLATO) trial, ticagrelor
reduced pneumonia. In the Targeting Platelet-Leukocyte Aggregates in
Pneumonia With Ticagrelor (XANTHIPPE) study, ticagrelor improved
lung function. We conducted a meta-analysis to investigate if ticagrelor
reduces the risk of infections.
Methods: We searched MEDLINE, EMBASE, Cochrane Library, and
ClinialTrials.gov for randomized controlled trials up to February 13, 2020
comparing ticagrelor and clopidogrel that have reported the incidence of
infections. The primary outcome in our meta-analysis was pneumonia.
Secondary outcomes were upper respiratory tract infection (URTI), urinary
tract infection (UTI) and sepsis. Risk ratios (RRs) and 95% confidence intervals
(CIs) were combined in a random-effects model using RevMan version 5.3.5.

20
Blood and Urine Inorganic and Organic Mercury Levels in the
United States: The United States National Health and Nutrition
Examination Survey (NHANES) 1999-2016
ASC So, MF Tsoi, AJ Cheung, TT Cheung, BMY Cheung
The University of Hong Kong, Hong Kong
Introduction: Mercury is an environmental hazard. Mercury toxicity is
highly associated with hypertension, coronary heart disease, myocardial
infarction, stroke and other cardiovascular disease. Therefore, we studied
recent trends in the blood level of organic and inorganic mercury in the
United States.
Methods: 56445 participants that had blood mercury and urine mercury
measurements in NHANES 1999-2016 were included. The organic
mercury level was obtained by subtracting the inorganic mercury level
from the total mercury level. Results were analyzed using SPSS complex
sample module version 25. Pregnant women and children aged <20
were analyzed as subgroups.
Results: Blood inorganic mercury level and urine mercury level have been
decreasing between 1999 and 2016 (p<0.001). Blood inorganic mercury level
decreased from (geometric mean [95% confidence interval]) 0.31 [0.310.31] in 1999-2000 to 0.21 [0.21-0.22] µg/L in 2015-2016 (p<0.001). Urine
mercury level decreased from 0.75 [0.71-0.80] in 1999-2000 to 0.16 [0.160.17] µg/L in 2015-2016 (p<0.001). In contrast, blood organic mercury level
increased from 0.08 [0.07-0.10] to 0.17 [0.16-0.18] µg/L during 1999-2016.
Blood organic mercury increased significantly (p<0.001) from 0.03 [0.02-
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Results: Out of 5476 citations, eleven trials with altogether 37569 patients
were included in the meta-analysis. Ticagrelor was associated with a lower
risk of pneumonia (RR 0.80, 95% CI 0.67 to 0.95) compared to clopidogrel.
In contrast, no statistically significant difference was observed for URTI
(RR 0.71, 95%CI 0.34 to 1.48), UTI (RR 1.09, 95%CI 0.73 to 1.64), or sepsis
(RR 0.79, 95%CI 0.50 to 1.26).
Conclusions: There is evidence that ticagrelor reduces the risk of pneumonia
compared to clopidogrel. However, there is no significant reduction in URTI,
UTI or sepsis. Pneumonia is usually due to Gram-positive pathogens, whereas
URTI is usually caused by viruses, and UTI and sepsis are usually caused by
Gram-negative bacteria. Our meta-analysis reinforces the post-hoc analysis of
PLATO and provides further evidence on the potential benefits of ticagrelor
in Gram-positive bacterial infections.

0.03] to 0.07 [0.06-0.07] µg/L in children aged <20 and from 0.14 [0.09-0.21]
to 0.36 [0.16-0.83] µg/L in pregnant women in this period.
Conclusion: A steady decline in both blood inorganic mercury level and urine
mercury level over the period 1999-2016 was observed, suggesting a reduction
in environmental pollution by inorganic mercury. The increase in organic
mercury, especially in children, adolescents and pregnant women, could be
related to changes in consumption of seafood.
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Reverse Wire Technique for Handling Acute Angle Bifurcation
V Pong, DKY Lo, CM Kong, SY Man, KW Chan, WHY Lam, NP Kwong
Yan Chai Hospital, Hong Kong
Background: Percutaneous coronary intervention (PCI) for bifurcation
lesion with angulated side branch is challenging.
Method: A 64 year old lady was admitted for late presented anterior ST
elevation myocardial infarction. Angiogram showed critical stenosis at
proximal left anterior descending (LAD) / first diagonal (D1) bifurcation.
The lesion was Medina 1,1,1 classification and the D1 takeoff angle was
acute. 6 French Ikari left (IL 3.5) guide catheter via right radial approach
was used. The D1, a significant side branch with tight ostial lesion, had a
high chance of closure during LAD intervention. The plan was to wire the
D1 for protection and for provisional stenting of proximal LAD. After wiring
the LAD, repeated attempts to wire the D1 with Sion Blue and Fielder FC
supported by microcatheters (Crusade and Supercross 120) were
unsuccessful. This is contributed by the angulated takeoff of D1 and tight
stenosis before the bifurcation.
Results: Subsequently we used the reverse wire technique. A hairpin-bend
was formed in the Fielder FC wire at a point 3 cm from the distal tip and
inserted in the Crusade microcatheter. The Fielder FC wire was passed via
Crusade into LAD beyond the bifurcation. After pulling back the
microcatheter, the reverse bent wire was withdrawn slowly which caused

22
Leadless Pacing with Micra TPS: Initial Experience at a
Regional Hospital in Hong Kong
V Pong, DKY Lo, CM Kong, SY Man, KW Chan, WHY Lam, NP Kwong
Yan Chai Hospital, Hong Kong
Background: Conventional transvenous pacemaker is associated with
significant risk of complications, primarily driven by lead related
complications.
Methods: We describe our initial experience with the Micra Transcatheter
Pacing System (TPS; Medtronic) including its indications, efficacy and
safety. Clinical data of patients who received Micra in Yan Chai Hospital
from March to April 2020 was retrieved and retrospectively analyzed.
Results: A total of four patients consented and underwent Micra implant in
the above named period. The mean age of the patients was 84.5 +/- 4.6
years, 50% had atrial fibrillation, 75% had diabetes, and 50% had chronic
kidney disease. Sinus node dysfunction was the main indication for pacing
in this cohort (50%), followed by atrial fibrillation with slow ventricular
response and atrioventricular block. No patients had prior device
implantation.

38

the wire to engage the ostium of D1. After exchanging Fielder FC with Sion
wire, the LAD and D1 were predilated. Proximal LAD was provisionally
stented with 3.0/19 drug eluting stent. Kissing balloon inflation at LAD
and D1 and proximal optimization technique with NC 3.5 balloon was
performed.
Conclusion: Reverse wire technique is effective and safe for approaching
highly angulated branches of bifurcation lesions.

The Micra system was successfully implanted in all of the patients. The
site of implant was mid right ventricular septum and only one deployment
was required in all of the patients. The mean implant duration was 50+/-8.6
minutes and fluoroscopy duration was 7.3+/-2.3 minutes. The average
implant threshold was 0.4+/-0.06 mV@0.24 ms, the R wave amplitude was
9.1+/-4.6 mV and impedance 932+/-178 Ohms. None of the patients had
high pacing threshold requiring repositioning of the Micra system. There
were no major complications during the follow up period.
Conclusions: Micra Implantation is a safe and feasible option, especially
in patients with multiple risk factors for device infection.
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Short Term Clinical Outcomes and Analysis of Risk Factors for
Pacemaker Implantation : A Single Center Experience of Selfexpandable Transcatheter Aortic Valves
SCY Chow,1 RHL Wong,1 GSH Cheung,2 APW Lee,2 HKL Chui,2 KCY So,2
EB Wu2
1
Division of Cardiothoracic Surgery, Department of Surgery, The Chinese
University of Hong Kong, Prince of Wales Hospital; 2Division of Cardiology,
Department of Medicine, The Chinese University of Hong Kong, Prince of
Wales Hospital, Hong Kong
Background: Permanent pacemaker (PPM) rates remain high for self
expandable TAVI valves. In this analysis we evaluate short term clinical
outcomes post self expandable TAVI and determine risk factors for
PPM implantation.
Methods: 88 patients with severe aortic stenosis with TAVI done between
the year 2016-2018 were retrospectively analyzed. Outcomes of interest
included 1- year all cause mortality, 30-day major adverse cardiovascular
events (MACE), PPM and paravalvular leak rates. Survival analysis was
performed with Kaplan Meier analysis and risk factors for survival and
PPM rates were identified with log rank test and regression analysis.
Results: The mean age of the cohort was 80.3 +/- 6.9 years. The mean STS
score was 9.25. The 30 day all-cause mortality was 5.7% and 1-year all cause
mortality was 16.7%. 90.1% of patients had transfemoral TAVI, with majority of
patients (85.2%) implanted with Corevalve Evolut R device. The device success
rate was 88.6%. Multivariate analysis identified concomitant severe coronary

37
SMART in Cardiology Nurse Clinic
KY Kwan, YW Leung, HY Fung, YB Ng, SCS Yue, PL Ngan
Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong
Background: Information technology (IT) - based innovations improve health
promotion and create more efficient and effective healthcare delivery systems.
"SMART" is an IT-based project launched in Cardiology Nurse Clinic - Preoperative Assessment (CNPA) since 2018. CNPA provides nurse-led
assessment for over 650 patients prior to cardiac interventions annually. It
comprises, i) initial assessment with laboratory tests and electrocardiogram,
ii) health education session, and iii) individual interview with patients and
relatives. In 2018, the health education session was modified from 1-hour
group talk to introductory videos demonstrated on tablet pc. QR code was
developed in 2019 facilitating video preview prior to clinic attendance and
sharing to clients' family.
Objectives: To review the effectiveness of SMART in CNPA.
Methods: Client satisfaction survey was conducted in October and
November 2019, incorporate with knowledge assessment with 4 closeended questions to evaluate clients' knowledge: i) need of fasting on
day of cardiac intervention, ii) need of shaving prior to cardiac
catheterization/percutaneous coronary intervention, iii) duration of use
of dual anti-platelet after drug eluting stent implantation, and iv) storage
of glyceryl trinitrate.
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artery disease (OR=18.2 +/- 0.9; P=0.002), pre TAVI atrial fibrillation (OR=8.6
+/- 0.91; P=0.02) and post TAVI disabling stroke ( OR=32.6 +/- 1.35; P=0.01) as
risk factors for 1-year mortality. The 30-day PPM rate was 17.6%. The presence
of right bundle branch block (OR 11.1 +/- 0.86 ; P = 0.005), non-coronary cusp
(NCC) implantation depth (OR=1.34 +/- 0.15; P=0.05) and a NCC implantation
depth / membranous septal length ratio of more than 50% were associated
with post TAVI PPM (OR=29.9 +/- 1.72; P=0.05). Among the 15 patients with
post TAVI PPM, 40% were found to be non-pacemaker dependent at 1 year.
Conclusion: Short term outcomes of TAVI in severe AS patients are promising.
Pacemaker rates remain high. More studies are needed to evaluate the factors
that influence PPM rates and PPM dependence to further improve TAVI
outcomes.

Results: All clinic attendees (n=108) were invited for the client satisfaction
survey with 95% response rate (5% being illiterate). 98% clients agreed that
the introductory video clearly disseminated relevant information about cardiac
interventions.
QR code facilitates video sharing and education. Over 97% clients agreed
that preview of video could effectively minimize consultation time. 73.8%
clients had video preview prior to clinic. Clients could watch the video
at their convenience, rather than watching at crowded and noisy corridor
in clinic. It is worth noticing that 92.1% clients shared the video with
their family, whom could not attend the clinic. Health promotion and
disease management were expedited among clients and family.
In the knowledge assessment, 86.4% clients scored all correct, revealing
that video effectively aided in clients' understanding of cardiac
interventional procedures.
Conclusion: IT transforms healthcare in new era, allowing more effective
exchange of information. With the simple utilization of SMART in
Cardiology Nurse Clinic, clients could benefit from shortening of
consultation time without health knowledge being compromised. Time
conserved also allows more cases to be catered in Cardiology Nurse
Clinic.
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Meta-analysis of Cardiovascular Outcomes in Clinical Trials
on Apabetalone
HL Li, Y Fei, Q Feng, BMY Cheung
Department of Medicine, The University of Hong Kong, Queen Mary
Hospital, Hong Kong
Background: Apabetalone is a novel drug that reduces inflammation
and thrombosis by inhibiting bromodomain and extra-terminal proteins
(BET) that regulate transcription. Three phase II trials suggested
cardiovascular benefits of apabetalone whereas a recent phase III trial,
BETonMACE (Ray et al. JAMA 2020 March 27), failed to show significant
benefit. To reconcile these inconsistencies, we performed a meta-analysis
of all trials on apabetalone.
Methods: MEDLINE, EMBASE, Cochrane Library, and ClinialTrials.
gov were searched for randomised controlled trials of apabetalone up
to May 05, 2020. The outcomes of interest were major adverse
cardiovascular events (MACE) and hospitalisation for heart failure.
The secondary outcomes were death, myocardial infarction (MI), and
coronary revascularisation. Risk ratios (RRs) and 95% confidence
intervals (CIs) were pooled with fixed-effects model using "meta"
package in R (version 3.6.3).

62
Local Experience in the Use of Proprotein Convertase SubtilisinKexin Type 9 (PCSK9) Inhibitors: A Case Series
SF Wong, TS Chung
United Christian Hospital, Hong Kong
Background: Evolocumab and Alirocumab are the current two FDA
approved Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9)
inhibitors that were well proven in randomised controlled trials (RCTs)
to lower LDL-cholesterol level and reduce cardiovascular outcomes in
adjunct to conventional lipid lowering agents. Yet local data regarding
their use are lacking. We would like to study on their use in real life
practice within the local population and compare the efficacy, dosing
regime and side effects profile in contrast to well-established clinical
trials.
Methods: We reviewed all clinical cases in a tertiary medical centre who
were put on PCSK9 inhibitors. All follow-up records of individual case
were reviewed and parameters including the LDL-cholesterol levels
and any adverse effects in relation to the drugs are analysed.
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Results: Four trials with altogether 3223 patients were finally included. All
patients had documented coronary artery disease and received standard statin
therapy. The median follow-up duration ranged from 12 weeks to 26.5 months.
Apabetalone significantly reduced MACE (RR 0.78, 95% CI: 0.63-0.96) and
hospitalisation for heart failure (RR 0.48, 95% CI: 0.33-0.70) compared to
placebo. No statistically significant difference was observed for death
(RR 0.87, 95% CI: 0.63-1.21), MI (RR 0.82, 95% CI: 0.62-1.10), and coronary
revascularisation (RR 0.67, 95% CI: 0.31-1.49). There was no significant
heterogeneity among the included trials.
Conclusions: Although the BETonMACE trial failed to demonstrate significant
benefits, our meta-analysis incorporating evidence from three earlier trials
shows that apabetalone may reduce MACE and hospitalisation for heart failure
in patients with coronary artery disease. While it is too early to recommend
apabetalone for clinical use, larger outcome trials are urgently needed to
investigate the benefits of epigenetic modulation through BET protein
inhibition.

Results: 18 cases are reviewed by far. Among which 7 of them are put on
Alirocumab while 11 of them are put on Evolocumab. All cases have a
background of atherosclerotic cardiovascular disease and were already put
on maximally tolerated dose of statin with or without Ezetimibe before the
introduction of PCSK9 inhibitors. All patient have shown a dramatic reduction
in LDL-cholesterol levels from a median baseline value of 2.5 mmol per litre to
0.8 mmol per litre over a median follow-up period of 4 months. The cholesterol
lowering effect appears to persist despite de-escalating the intensity of therapy
with PCSK9 inhibitors. There was no adverse reaction observed so far except
from insignificant rise of liver transaminases (i.e. <3x upper limit of normal).
Conclusion: Addition of PCSK9 inhibitors on a background of statin therapy
significantly lowers LDL-cholesterol level in patients with atherosclerotic
cardiovascular disease in our locality, a finding largely comparable to RCTs.
The efficacy appears to persist even with doses lower than recommended.
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Transcatheter Tricuspid Valve Replacement and Repair: Pooled
Analysis of the Outcomes and Complications of Novel Emerging
Treatments
Y Khalid,1 N Dasu,1 K Dasu2
1
Rowan University, Stratford; 2 Syracuse University, Syracuse, United
States
Background: Tricuspid regurgitation is a poor prognostic marker of
end-stage heart failure. Treatment options for severe tricuspid
regurgitation are currently limited because these procedures have the
highest mortality rates of all valve procedures. Transcatheter tricuspid
valve repair or replacement (collectively, TVTT), on the other hand,
are extremely promising interventions due to the minimally invasive
nature of these treatments.
Objective: The aim of this study is to examine the complications of
these procedures from day 0 of procedure to up to 1 year of follow up.
Methods: Six studies were included from 3 registries (TriVALVE,
TRILUMINATE, TRAMI), surveying a total of 336 patients. Complications
following the procedures were pooled and analyzed.
Results: From procedure to up to 1 year, there was 14.3% mortality (49/342),
0.3% incidence of myocardial infarction and TIA/stroke (1/342), 2% device
embolization and/or leaflet detachment (7/342), 5.2% major/minor bleeding
(18/342), 0.9% AKI (3/342), 1.1% infections and arrhythmias (4/342).

65
Short Term Outcomes with MitraClip in Women Compared with
Men: Evidence From a Meta-Analysis
Y Khalid, 1 N Dasu, 1 K Dasu 2
1
Rowan University, United States; 2Syracuse University, United States
Objectives: This study sought to examine short-term outcomes with
transcatheter mitraclip in women versus men.
Background: MitraClip is now approved for severe functional mitral
regurgitation in high-risk patients with contraindications to surgical
mitral valve repair. Previous studies have shown conflicting results with
respect to sex differences in outcomes with the MitraClip.
Methods: Electronic search was performed until April 2020 for studies
reporting outcomes with MitraClip in women versus men. Random
effects DerSimonian-Laird odds ratios were calculated. Outcomes
included all-cause mortality and major cardiovascular events at shortterm follow-up (in hospital or 30 days) as well as complications.
Results: Six studies (4 MitraClip registries; 2344 patients; 925 women)
were analyzed. Women were older but exhibited fewer comorbidities.
At 30 days, men had more stroke (p<0.0347) and major vascular
complications (p<0.042), without a difference in all-cause and
cardiovascular mortality (OR 1.31, 0.67-2.57, p<0.43) compared with
men. There was no difference in pericardial effusion/cardiac tamponade
(p<0.311) or acute renal failure (p<0.805). However, for 4 of the studies,
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Conclusions: Despite a narrow sample size due to the novelty of these
procedures and varying lengths of follow-up (30 days to 1 year), transcatheter tricuspid valve repair and replacement prove to be promising
interventions. Mortality was significant at 14.6%, but patients with severe
tricuspid regurgitation have a poor prognosis overall without
intervention along with higher comparative mortality rates. Research
aimed at further investigating TVTT procedures and prospective clinical
trials to establish these treatments as mainstays for severe tricuspid
regurgitation is necessary.

female sex was associated with lower all-cause mortality at 1 year
(p=0.01), potentially caused by less moderate/severe aortic insufficiency
(p=0.001), and lower cardiovascular mortality (p=0.009). The female survival
advantage remained consistent across multiple secondary analyses. The risk
of stroke, moderate/severe aortic insufficiency, and all-cause mortality seemed
to vary based on the type of valve used; however, without significant subgroup
interactions.
Conclusions: Despite conflicting data, women experience better shortterm outcomes with the MitraClip repair.
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On the Verge of Death: A Case of Fulminant Myocarditis
YK Yeung
Queen Elizabeth Hospital, Hong Kong
Background: This is a case of fulminant myocarditis with rapid
progressing heart failure which is managed by early mechanical
circulatory support and guided by invasive hemodynamics.
Case: A 48-year-old gentleman had a past medical history of alcohol
dependence syndrome. He presented to AED with chest pain and
shortness of breath. Initial electrocardiogram showed anterior STsegment elevation and primary PCI was activated. He was
hemodynamically stable when presenting at AED. Upon transferal, he
was noted to have fever and unstable hemodynamic requiring inotropic
support. On-table echocardiogram showed poor LVEF 30-35% with no
regional wall movement abnormalities. Coronary angiography showed
normal coronaries. Initial blood work showed normal white cells and
differential, normal liver and renal function and elevated hsTnI up to
3465. Chest X-Ray showed normal heart size with no congestion. In
view of fever with cardiogenic shock and normal coronary angiography,
patient was suspected to have myocarditis. Patient was subsequently
transferred to CCU for close monitoring. He was started on empirical
antibiotics, intravenous thiamine and inotropic support. On the next
day, he had increasing dyspnea requiring oxygen supplement. Chest
X-ray showed increased pulmonary congestion and echocardiogram showed
deteriorated LVEF to 15-20%. In light of rapid deteriorating hemodynamics

23
A Nightmare: Fractured Rotawire
V Pong, DKY Lo, CM Kong, SY Man, KW Chan, WHY Lam, NP Kwong
Yan Chai Hospital, Hong Kong
Background: Percutaneous coronary intervention (PCI) for heavily
calcified lesions can be a nightmare.
Case: An 82-year-old lady, good premorbid, with diabetes mellitus and
hypertension, was admitted for non ST elevation myocardial infarction.
Coronary angiogram showed heavily calcified left anterior descending
artery (LAD) with mid LAD 80% stenosis. Patient and family were very
keen for high risk PCI and accepted the increased risks.
7 French EBU 3.5 guide via right radial approach was used. The mid
LAD calcified lesion was undilatable with 1.5 mm balloon and thus proceeded
for rotablation. The workhorse wire was exchanged to Rota floppy wire and
1.5 mm burr rotablator was used. During testing of the rotablator advancer
outside the body, the wire clip torquer was inserted into the brake docking
port instead of gripping the rotawire. Fluoroscopy showed distal rotawire
fracture and retention of the radiopaque segment at distal LAD.
Decision making: Treatment options included wire retrieval versus crushing
the wire against the vessel wall with stent. Twist wire technique to retrieve the
retained wire segment was attempted. Two Runthrough wires were placed at
distal LAD and one at septal branch. Nevertheless, the technique failed as the
rotational torque could not be transmitted through the calcified segment. This
was further complicated by proximal LAD dissection while pulling out the
twist wire system. Further contrast injection was minimized. Initial wiring with
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and working diagnosis of myocarditis, early use of mechanical circulatory
support was initiated. Right heart catheterization showed elevated mPAP of
30 mmHg and PCWP of 22 mmHg. Endomyocardial biopsy was performed for
diagnosis. Impella CP was inserted subsequently. However, patient was further
deteriorated with respiratory failure requiring mechanical ventilatory support,
acute renal failure and lactic acidosis despite impella support. IVIG was also
given. Peripheral VA-ECMO was established and patient was started on
hemodialysis. Patient was stabilized with VA-ECMO and Impella for LV venting.
Levosimendan infusion was given. There was gradual improvement in
hemodynamics and oxygenation. Serial echocardiogram showed improved
biventricular function. Decannulation of VA-ECMO and impella removal were
performed on Day 9. Patient was subsequently extubated. Follow-up
echocardiogram showed normal LVEF 60-65%. Endomyocardial biopsy showed
scanty detached necrotic cardiomyocytes with patchy lymphocytic infiltrate.
Decision making: This case highlighted the importance on the early recognition
of fulminant myocarditis and initiation of mechanical circulatory support
including impella and VA-ECMO. It is essential for the maintenance of endorgan, resulting in favorable outcome among which were previously almost
universally fatal.
Conclusion: Fulminant myocarditis is characterised by rapid
hemodynamic deterioration and poor outcome. Early recognition and
initiation of mechanical circulatory support are of paramount importance
for favorable outcome.

microcatheter went into a high diagonal branch and eventually the wire was
redirected into distal LAD. The mid LAD calcified lesion was aggressively
predilated with multiple NC, Angiosculpt and shock wave balloons. The patient
required inotropic support for ischemic symptoms during deep seating of
guide catheter and Guideliner occlusion of LAD. The retained rotawire segment
was crushed with 2.0/38 drug eluting stent (DES) and the proximal LAD was
stented with 3.0/38 DES. Subsequent angiogram noted wire perforation at a
proximal small diagonal branch with contrast staining. There was no pericardial
effusion. The bleeding site was identified by balloon testing and 3.5/15 covered
stent was deployed at ostial LAD. Final angiogram was good. The patient
gradually weaned inotropes and had an uneventful postoperative recovery.
Conclusions: Fracture and retention of rotawire is a very rare complication
and can be safely treated by stenting the wire. Always follow the checklist
before activating the rotablator.
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Too Young to Die

Decision making:
1. Impella versus IABP support for staged PCI to LCA
2. Manual compression versus Proglide for LFA not preclosed
3. What caused LFA total occlusion? Sutures or thrombus

SSM Wong, PT Tsui
Princess Margaret Hospital, Hong Kong
Background: Mr. Chung was a male 39 years old diabetic with nephropathy
and retinopathy. He defaulted follow up from 2014-2018 and had been admitted
because of buttock necrotizing fasciitis and Fournier gangrene with poor wound
healing. Transverse colostomy was performed for de-functioning purpose. He
was admitted to PMH in December 2019 because of unresponsiveness and
shock and then transferred to ICU for inotropic support and CRRT. Cardiac
team was consulted because of two episodes of PEA arrest in ICU (downtime
9 + 3 min). He was intubated and his ECG showed ST elevation over II, III and
ST depression over V2-4. Echo showed LVEF <40% and global hypokinesia.
Case: Emergency PPCI was performed to RCA. He developed PEA arrest
again during PCI and required transient LUCAS support. Staged PCI to LM
and LAD was then performed with Impella 2.5 support. Procedure was
uneventful with only transient hypotension treated by Impella boosted support.
Continued Impella support via LFA was provided for 4 days. The LFA was not
pre-closed. Impella driveline was punctured and guidewire was passed into
abdominal aorta. The whole system was then advanced to the thoracic aorta
and the guidewire was then freed from the Impella driveline. Two Proglide
sutures were applied. After hemostasis, cross over angiogram showed blocked
LFA. Attempted PTA to LFA failed. Surgical exploration and clot evacuation
was performed. He developed severe left groin wound infection requiring
multiple debridement surgery.

36
Broken Arrow
YH Cheng
Pok Oi Hospital, Hong Kong
Background: CTO PCI is a complicated procedure requiring a wide
repertoire of skill sets as well as numerous equipment. Unfortunately, the
success rate for CTO PCI still remains lower than conventional PCI while
having a higher chance of complication. Here, we present a case with a
complication involving equipment failure and a novel method to
tackle it.
Case: Mr. M, a 75-year-old gentleman presented with stable angina He was
brought in for coronary angiogram as well as percutaneous coronary
intervention. Diagnostic coronary angiogram showed mLAD CTO with a
blunt stump. The CTO was eventually crossed with Gaia Second supported
by Caravel microcatheter.
However, the Caravel microcatheter failed to advance through the lesion.
Further manipulation of the microcatheter yielded no progress. Upon
withdrawal of the microcatheter, the tip of the microcatheter broke off and
was stuck inside the mLAD lesion.
Decision making: We decided to try using Rotablation to destroy the tip.
A Rotawire was passed through the lesion, through the tip of the
microcatheter and a 1.25 mm burr was used to rotablate the broken Caravel
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tip as well as the CTO lesion at 160 000 rpm with multiple passes. Further
balloon dilatation and the mLAD lesion was stented with TIMI 3 flow
achieved.
Conclusion: To our knowledge, this is the first case to use Rotablation for
successfully bailing out a retained device inside a coronary lesion.
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"Double Sieve" in Coronary Intervention
KC Un, AYT Wong, FCC Tam
Queen Mary Hospital, Hong Kong
Background: We present a case of rotablation complicated by coronary
perforation and our subsequent management.
Case: YM Au, F/70, with history of hypertension and diabetes, presented
to the medical ward with NSTEMI. TnT rose to 1354. Echo showed
normal LVEF. Coro showed p-mRCA 90% disease, pLCx 70-80% disease,
mLAD 60-70% disease. In view of triple vessels disease, coronary surgery
was offered to patient but was declined. PCI to RCA was then performed
with rotablation and two DES was implanted. Stage PCI to left coronary
arteries was performed afterwards. IVUS was unable to advance into
LAD/LCx due to tight calcified stenosis and tortuosity. Rotablation to
LAD was performed with 1.5 Burr and 1.25 Burr. Angiogram and
IVUS showed contained rupture (Class I perforation) at pLAD. mLAD
was then stented and LM-LAD-LCx bifurcation stenting was performed
over the perforation. Stent at pLAD was post-dilated with NC 3.0.
Subsequent angiogram showed static perforation and no extravasation.
Decision making: In view of static pseudoanerysm size, patient was put on
close observation. CABG with surgical repair may not be optimal in view of
small distal vessel. Cover stent was also not the first option in view of close
proximity with septal and diagonal branches. Reassessment CT coro one month
later showed static coronary pseudoaneurysm sizes.

59
Challenges and Solutions from a Very Elderly Patient in Renal
Insufficiency: Atrail Flutter With Congestive Heart Failure And
Acute Deep Venous Thrombosis
B Luo, Y Li, L Xu
The First Affiliated Hospital of Guangzhou Medical University,
Guangzhou City, China
Background: Both atrial flutter and deep venous thrombosis require
anticoagulation therapy, but there are no reports or guidance for the
very elderly with renal insufficiency.
Case: The 88-year-old male patient with upper abdominal pain for four days
was admitted to the surgical ward. After admission, the patient was transferred
to the cardiac unit due to an atrial flutter attack. The patient has a history of
palpitation and shortness of breath after activity for more than three years and
renal dysfunction more than four years without any medications. He denied a
history of hypertension, diabetes, stroke, and coronary heart disease. He has
a 50 pack-year history of smoking. The patient still could take good care of
himself. Physical signs showed R 28, BP132/94 mmHg, HR 136 beats/min.
Tenderness under xiphoid positive, swollen legs and a.
Examination result: NT-pro-BNP 7575.00 pg/mL, SCr: 164.40 umol /L, Body
Weight 42 Kg, eGFR 16.35 ml/min, D-dimer: 1728 ng / ml, EKG showing Atrial
flutter (typical), 2: 1 conduction. HOLTER showing persistent atrial fibrillation
and frequent ventricular premature beats (6.2%). The echocardiography
appeared as mitral regurgitation (moderate to severe), aortic regurgitation
(mild), tricuspid regurgitation (severe), pulmonary hypertension (mild), right
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However reassessment coro two months later showed interval increase in size
of the pseudoaneurysm. IVUS also showed increase in pseudoaneurysm size
with LAD stent undersizing and malapposition. A Bare metal stent was implanted
and post-dilated with NC 3.0 and NC 3.5. Covered stent was considered to be the
next option if restudy coro showed further increase in size of the
pseudoaneurysm. Subsequent coronary angiogram three months later showed
interval decrease in size of the pseudoaneurysm and was resolved six months
later.
Conclusion: This case illustrated our approach towards coronary
pseudomaneurysm as a serious complication after rotablation. Extra
care should be taken during rotablation process and we should be wellprepared to tackle the potential complications.

atrium enlargement, EF24%, left ventricular wall Widely weakened. lower limb
venous vein echo appeared as the intermuscular vein of the right calf muscle
vein thrombosis widened to 3 mm.
Decision making: (1) What are the main complaints and diagnoses of the
patient? (2) What is the differential diagnosis according the clinical situation?
(3) What is the decision for anticoagulant therapy? (4) How to perform rate
control therapy? (5) Whether should we perform ablation to maintain rhythm?
(6) What are the ablation risks to the patient? Finally, the 88-year-old patient
underwent ablation and anticoagulation. EF value was up to 69% with persistent
sinus rhythm after three months follow-up, and echo showed the right calf
muscle vein thrombosis in the limb has gone.
Conclusion: The treatment indications should be strictly grasped to improve
the prognosis and quality of life for very elderly patients. Elderly patients with
tachycardia cardiomyopathy can benefit from sinus rhythm maintenance, and
anticoagulants can also be safely and effectively used for the very elderly
atrial flutter with comorbidity of deep vein thrombosis and chronic kidney
disease.
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A Rare Case of Acute Cerebral Embolism from Left Atrial
Myxoma Complicated by Postoperative Atrial Fibrillation
Y Khalid, 1 N Dasu,1 M Daneshvar, 1 V Sailam 2
1
Rowan University; 2Virtua Health Cardiology, USA
Background: Primary cardiac tumors are those that originate in the
heart and are extremely rare. Myxomas are the most common form of
primary cardiac tumors. They have a variety of presentations, such as
constitutional symptoms, cardioembolic events like cerebrovascular
accidents (CVA), or hemodynamic abnormalities. Paroxysmal atrial
fibrillation (PAF) is a well-known postoperative complication of coronary
artery bypass grafting (CABG), but there are extremely few cases of
PAF occurring post-operatively after left atrial myxoma surgical
resection.
Case summary: We present a case of a 69-year-old female with a history of
subarachnoid hemorrhage (SAH) who was diagnosed with CVA secondary to
thromboembolism from left atrial myxoma. She then developed atrial fibrillation
which required cardioversion.
Discussion: This case presents a challenge in terms of keeping left atrial
myxoma as part of the differential diagnosis for cardioembolic CVA;
deciding optimal timing for surgical resection; and finally, how to
manage the subsequent new-onset atrial fibrillation.

69
A Rare Case of End-stage HF Salvaged by Rescue Cardiac
Resynchronization Therapy (CRT)
Y Khalid, 1 N Dasu, 1 P Jang,1 K Dasu2
Rowan University; 2Syracuse University, USA

1

Background: End-stage heart failure (HF) is defined as lack of
improvement of HF symptoms and frequent exacerbations despite
maximal medical therapy. Current guidelines recommend against the
use of Cardiac Resynchronization Therapy (CRT) as a rescue device in
end-stage HF.
Case report: We present a case of an unconventional approach using CRT to
treat refractory end-stage HF. A 76-year-old male presented with two days of
worsening shortness of breath, hallucinations, and confusion.
A transthoracic echocardiogram (TTE) showed an EF of 20-25% with globally
reduced wall motion function. The patient was restarted on his home
medications and given intravenous (IV) lasix, which improved the patient's
mental status and generalized edema. However, his creatinine increased, and
nephrology recommended holding his sacubitril/valsartan and carvedilol due
to persistent hypotension. He was then noted to have worsening dyspnea on
exertion, episodes of hallucinations, and confusion. The patient was intubated
and upgraded to the intensive care unit due to increased work of breathing
with hypoxia. He was diagnosed with end-stage HF and cardiogenic shock
based on clinical and physical exam findings of cool extremities, altered mental
status, and decreasing heart rate. He was started on dobutamine and
norepinephrine infusions with improvement in all of his clinical symptoms.
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After three days, the patient was extubated, but he could not be weaned
from the dobutamine infusion. Palliative care recommended home
hospice with a palliative dobutamine infusion. A repeat EKG showed
worsening LBBB now with QRS 213 ms.
Decision making: Electrophysiology recommended CRT with a defibrillator
because the patient met EKG criteria for the device with a wide QRS of 230 ms
and a LBBB. After CRT, the patient was hemodynamically stable with cessation
of the dobutamine infusion. His kidney function continued to improve on the
day of discharge - the lowest it was noted in years. He was also able to restart
all of his goal directed medical therapy. After discharge, a repeat TTE showed
an improved EF of 30-35%.
Conclusions: CRT is a promising intervention for new-onset end-stage HF for
patients who may be able to recover enough of their EF to restart GDMT. This
report highlights the promising clinical outcome of an unconventional CRT
use in end-stage HF despite a level C recommendation in current guidelines.
Further studies are required to validate these findings and to establish the
causes of these observations.
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Clinical Study of Blunt Cardiac Rupture in Childhood: A Report
of 5 Cases
J Zheng, X Li, Z Li
Beijing Children's Hospital Affiliated of Capital Medical University, Beijing,
China
Background: Cardiac injury is among the most lethal lesions in human
history. Patients would inevitable die until 1882. It first report that Dr.
Ludwig Rehn successful sew the broken heart1. Recently, most people
agree that a prompt diagnosis and suitable treatment can save lives.
However, there is no widely acceptable golden standard diagnostic test.
It is difficulty to quantify on how to establish the diagnosis. In western
country database, we usually find that most cardiac trauma happens at
youth (age around 30 years). leading cardiac injury caused including
motor vehicle accident, gunshot wounds, stab wounds. Consider the
anatomical site of lesions, two ventricle was the most affect site.
Compared with their data, our hospital patients have their special features.
It is worthy to conclude and research.
Method: During the 10 years, we collect data from 5 patients, age around 4-to9 years old. 4 patients are female. All of them suffered blunt cardiac injury.
Two of them injury caused by heavy object acting on chest, NO.1 is medal
stairs, NO.2 is heavy gate . NO.3, NO.4 catches the drifting-down injury (drop
from 2th floor). NO.5 injury by fast speed motorcycle accident. Cardiac
tamponade happen in all patients. The heart-shock happen in all patients.
Echocardiacgrphy shows large fluid in pericardium. Jugular veins are distend.
Chest X-ray reveal a widene d mediastinum. The hemodynamic stability at
origin. Usually the systolic blood pressure trend down slowly.

7
N-terminal Pro-brain Natriuretic Peptide as a Biomarker for
Predicting Coronary Artery Lesion of Kawasaki Disease
X Zheng,1,2 Y Li1,2
Department of Pediatrics, West China Second University Hospital of
Sichuan University; 2Key Laboratory of Birth Defects and Related Diseases of
Women and Children of MOE, West China Second University Hospital, Sichuan
University, Chengdu, China

1

Background: Coronary artery lesion (CAL) caused by Kawasaki disease
(KD) is currently the most common acquired heart disease in children
in many countries. Nevertheless, there is no single useful marker existing
for predicting CAL of KD. Recently, many reports have noted that Nterminal pro-brain natriuretic peptide (NT-proBNP) can be utilized as a
biomarker to predict CAL. Thus, we perform a meta-analysis to ascertain
the diagnostic value of NT-proBNP in detecting CAL of KD in the acute
phase.
Methods: PubMed, the Cochrane Central Register of Controlled Trials,
EMBASE, and China National Knowledge Infrastructure were searched
to detect relevant publications. Meta-Disc 1.4 was utilized to perform
data analysis. Besides, STATA 15.1 (Stata Corporation, College Station,
Texas, USA) was utilized to assess the publication bias and perform
meta-regression analysis. Homogenous results utilized the random-effects
model for statistical analysis, while the heterogeneous (I2 <50%) results
utilized a fixed-effects model, and the data were presented using a
forest map.
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Result: We finally transport all patients to operation room. By making the
median sternum incision, blood and clot were seen in the pericardial space.
Reassure the diagnosis hemo-pericardium. All 5 patients damage site around
right atria from their connections to the super vena cava. Usually the surgeon
can use small satinsky clamp stop bleeding then sew it by prolen suture. They
all recover soon after the emergency operation. During the follow up research,
all data go back to normal.
Conlusion: In China, limit by the transport and experience protocol of
tauma patients. penetrating cardiac rupture patients usually die at scene.
For the blunt cardiac injury patients, the most easy rupture site is around
the svc and right atrium. Without CPB, surgeon can sew it. It is baded on
prepare the diagnosis view.

Results: Finally, eight eligible studies were included. The overall diagnostic
sensitivity and specificity were 0.84 (95% confidence interval [CI]: 0.78-0.89)
and 0.71 (95% CI: 0.68-0.75), respectively. The area under the summary receiver
operating characteristic curves value (SROC) curve was 0.8582±0.0531.
Moreover, the overall sensitivity and specificity across five studies adopted
the threshold of approximately 900 ng/L were 0.82 (95% CI: 0.73-0.89) and 0.72
(95% CI: 0.68-0.76), respectively. SROC was 0.8868±0.0486.
Conclusion: This meta-analysis would be the first one to describe the role of
NT-proBNP in detecting CAL of KD.
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Diagnostic Significance of Circulating MiRNAs in Kawasaki
Disease
X Zheng,1,2 Y Li1,2
Department of Pediatrics, West China Second University Hospital,
Sichuan University; 2Key Laboratory of Birth Defects and Related Diseases of
Women and Children of MOE, West China Second University Hospital, Sichuan
University, Chengdu, China
1

Background: As the most common cause of acquired heart disease in
children in developed countries, there is still no golden standard available
in diagnosing Kawasaki disease (KD). With the rapid development of
molecular biology, many studies concentrated on the association between
the microRNAs (miRNAs) and the risk of KD. Thus, we perform this metaanalysis to find out the role of circulating miRNAs as a biomarker in detecting
KD.
Methods: We searched PubMed, EMBASE, the Cochrane Central
Register of Controlled Trials, and China National Knowledge
Infrastructure through Mar 10th, 2019. We conducted a meta-analysis
in a fixed/random-effect model using Meta-disc 1.4 and STATA 15.1.
Results: Six eligible articles were included in this meta-analysis. The overall
performance of total mixed miRNAs (TmiRs) detection was: pooled sensitivity,
0.7 (95% confidence interval [CI], 0.66 to 0.74); pooled specificity, 0.87 (95%CI,
0.83 to 0.90); and area under the summary receiver operating characteristic

9
Significance of Platelet Function and Parameters in Kawasaki
Disease
X Zheng,1,2 Y Zang1,2
Department of Pediatrics, West China Second University Hospital,
Sichuan University; 2Key Laboratory of Birth Defects and Related Diseases of
Women and Children of MOE, West China Second University Hospital, Sichuan
University, Chengdu, China
1

curves value (SROC), 0.8302. The meta-regression analysis suggested that
the specimen types, the composition of the control group, and types of the
reference miRNA were not responsible for the existing heterogeneities. The
subgroup analysis showed that SROC of the plasma group (0.8890) was more
significant than the serum group (0.7204), and SROC of the non-healthy control
(non-HC) group (0.9622) was more significant than the HC group (0.8096).
Conclusions: This is the first meta-analysis show that miRNAs may be used
as novel biomarkers for detecting KD, especially for distinguishing KD from
other febrile diseases. Besides, plasma is recommended as the clinical specimen
for diagnostic detection.

<0.01). Besides, the MPV level was 9.55fL with sensitivity of 75% and
specificity of 70% (AUC=0.733, 95%CI: 0.620-0.846, P<0.001).
Conclusion: This is the first longitudinal study of platelet function changes
in KD patients using PFA-200. Besides, lower PDW and MPV may be available
markers for early diagnosis of KD.

Background: Kawasaki disease (KD) is a systemic febrile, inflammatory
vascular disease of unknown etiology. The coronary artery abnormality
(CAA) caused by KD has become the most commonly acquired heart
disease in children. Initial treatment of intravenous immunoglobulin
(IVIG) can reduce the incidence of CAA. Thrombocytosis is common
during the course of KD, but changes in and significances of platelet
function and parameters are unclear.
Methods: In this study, we enrolled 120 patients, including 40 patients
with KD, 40 febrile controls, and 40 afebrile controls. The platelet
function was assessed using the platelet function analyzer (PFA)-200.
Platelet parameters, including platelet count (PLT), mean platelet volume
(MPV), platelet distribution width (PDW), and platelet hematocrit (PCT)
were measured.
Results: In the febrile period, the PDW and MPV were lower in KD patients
(P<0.05). The platelet function did not change significantly during the febrile
period of KD but weakened in the defervescence phase. No significant
differences between the CAA and normal groups, and between IVIG resistance
and response groups. The diagnostic cutoff value of the PDW level for
predicting KD was 10.85fL with a sensitivity of 55% and a specificity of 77.5%
(area under curve (AUC)=0.690, 95% confidence interval (CI): 0.574-0.806, P
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Efficacy of Infliximab for the Treatment of Kawasaki Disease
X Zheng,1,2 Y Li1,2
1
Department of Pediatrics, West China Second University Hospital,
Sichuan University; 2Key Laboratory of Birth Defects and Related Diseases of
Women and Children of MOE, West China Second University Hospital, Sichuan
University, Chengdu, China
Background: Kawasaki disease (KD) is an acute vasculitis of unknown
cause which predominantly affects children. Coronary artery lesions
(CAL) are a severe complication of KD. Initial treatment with intravenous
immunoglobulin (IVIG) can reduce the incidence of CAL.
Approximately 10-20% of KD patients are resistant to the primary IVIG
(rKD). Infliximab may decrease the rate of CAL and rKD. We performed
this meta-analysis to evaluate the efficacy of infliximab for the treatment
of KD.
Methods: Studies related to infliximab for the treatment of KD were
selected from PubMed, EMBASE, the Cochrane Central Register of
Controlled Trials, and China National Knowledge Infrastructure through
May 24th, 2019. STATA Version 15.1 was used for meta-analysis fixed/
random-effects estimates.
Results: We included nine articles in this meta-analysis. No significant
differences were recorded between groups in the incidence of CAL (risk ratio
(RR), 0.97; 95%CI (0.72, 1.31); p=0.84), the maximal Z-score of either coronary
artery (Zmax) (the mean standard deviation (SMD), 0.19; 95%CI (-0.28, 0.65);
p=0.43), the rate of rKD (RR, 0.65; 95%CI (0.39, 1.09); p=0.10), the days of

27
Cellular Functional and Transcriptomics Study in Gene
Mutations Associated with Congenital Heart Defects
HX Chen,1 ZY Yang,2 HY Wang,2 HT Hou,1 J Wang,1 Q Yang,1 GW He1,3,4,5
1
Center for Basic Medical Research & Department of Cardiovascular
Surgery, TEDA International Cardiovascular Hospital, Chinese Academy
of Medical Sciences & Peking Union Medical College, Tianjin, China;
2
College of Life Sciences, Nankai University, Tianjin, China; 3Department
of Cardiovascular Surgery, The First Affiliated Hospital, Zhejiang
University, Hangzhou, China; 4School of Pharmacy, Wannan Medical
College, Wuhu, China; 5 Department of Surgery, Oregon Health and
Science University, Portland, USA
Purpose: Congenital heart defects (CHD) is the most common congenital
anomaly in newborns. The causes of CHD are complex and not fully
understood. A number of genetic studies have linked gene mutations to
cardiac abnormalities. In this study, the stable human pluripotent stem
cell (hPSC) lines with two mutations identified from a patient with
complex CHD were established. We aimed to investigate the possible
pathways and pathogenic mechanism of CHD in mRNA levels using
transcriptomics study.
Methods: Two novel mutations (LTBP2 c.2206G>A, TCTN3 c.1268G>
A) were identified from the CHD case by whole exome sequencing
(WES) in previous study. The CRISPR/Cas9 system was used to generate
hPSCs with mutations (hPSCsmut) separately. The hPSCsmut cells were
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hospital (SMD, -0.82; 95%CI (-2.06, 0.42); p=0.20), and the rate of
severe adverse events (SAEs) (RR, 1.18; 95%CI (0.70, 2.00); p=0.53).
Meanwhile, subgroup analysis showed infliximab had no effect on the incidence
of CAL either as an initial treatment for KD or as a treatment for rKD.
Conclusion: Infliximab is not associated with reductions in the incidence of
CAL, rKD, days of hospital, and SAEs in KD patients. Further well-designed
randomized and prospective clinical trials with a larger number of patients are
needed to evaluate the efficacy of infliximab.

then inducted and differentiated into cardiomyocytes (CMsmut). RNA
sequencing technology was performed to detect the differentiation
efficiency and contraction of CMsmut and identify pathways involved
in CHD in day 0, 9, 13.
Result: The stable hPSCs-LTmu/TCmu were established, then inducted
and differentiated into CMs (hPSCs-CMs-LTmu/TCmu). Compare to
the wild type (hPSCs-CMswt), there were no significant differences in
cell pluripotency and differentiation efficiency. The cell contraction
was observed in the 8th day and lasted to the 13rd day, the contraction
of hPSCs-CMs-LTmu was faster and hPSCs-CMs-TCmu was slower than
hPSCs-CMswt. Transcriptomics analysis showed that the most significant
changes occurred in hPSC-CMs- TCmu group, 77 genes were downregulated in day 0 and 2321 genes were down-regulated in day 13,
compared with hPSCs-CMswt. In contrast to the changes of gene
expression pattern of persistent up-regulation in the group hPSCs-CMLTmu, there was no persistent up-regulated expression pattern in group
hPSCs-CM-TCmu.
Conclusion: Base on cell model (hPSCs-CMs-LTmu/TCmu) in vitro,
transcriptomics analysis suggested that LTBP2/TCTN3 mutations affect
genes expression in mRNA levels, some pathways in cardiac development
were enriched.These two mutations also affect contractility (rate and
force) of cardiac myocytes and may affect the development of the
heart. These findings provide new insights into the pathogenesis of
CHD.
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Re-evaluation of the Criteria for Asymmetric Amplatzer Occluders
in the Closure of Perimembranous Ventricular Septal Defects:
A Case Series Report
Y Li
West China Second University Hospital, Sichuan University, China

Conclusion: The application of an asymmetric Amplatzer occluder
expands the range of indications for patients with superior localized
VSD but is largely limited in cases with aortic valvar prolapse and large
VSD sizes. All successful cases recovered from arrhythmia postprocedure.

Objective: To discuss suitable criteria for the application of asymmetric
Amplatzer occluders for perimembranous ventricular septal defects
(pmVSDs).
Methods: We retrospectively studied 18 children with perimembranous
VSDs who underwent attempted asymmetric occluder closure between
January 2015 and December 2018 in our center. We analyzed the diameter
of the defects with the receiver operating characteristic curve (ROC)
values, the size of the occluders attempted, the presence of aneurysm
and the presence of aortic valve prolapse for each patient. Then, for
patients who experienced successful device implantation, the therapeutic
efficiency was evaluated by follow-up.
Results: Only 5 out of a total of 18 patients completed successful device
implantation. Compared with failed cases, successful cases demonstrated
a significantly smaller VSD size (5.46±1.03 mm vs. 8.73±2.33 mm,
P=0.012) and had a low ratio of aortic valvar prolapse (20% vs.
76.92%, P=0.026). Four out of 5 successful cases involved arrhythmia
complications, but the rhythm of the heart recovered after drug treatment.
According to the ROC and Youden analyses, the cut-off value of the defect
size for successful asymmetric Amplatzer occluder implantation was no larger
than 5.7 mm.

43
Gene Therapy for Hypertrophic Cardiomyopathy Targeting
mir-133 Using AAV System
L Liu, K Zhou
Department of Pediatric Cardiology, West China Second University
Hospital, Sichuan University, Chengdu, Sichuan, China
Background: Hypertrophic cardiomyopathy (HCM) is an autosomal
incomplete dominant hereditary disease, with the asymmetrical
hypertrophic of ventricular, disorder arrangement of muscle bundle
and fibrosis. Owing to shortage of effective treatment, the majority of
HCM patients could only choice to heart transplantation for live at the
advanced stage of disease, which caused a heavy burden for the patients
of HCM, and their family, even the society. Therefore, focusing on the
mechanisms of HCM to find an effective target is becoming more and
more urgency.
Methods: The mice under general anesthesia were opened the abdomen
and isolated the abdominal aorta. Ligation with a rod of 0.26 mm diameter was
taken for abdominal aortic constriction. Four weeks after the operation,
immunofluorescence staining of myocardial tissue was used to evaluate the
morphology, size and arrangement of myocardial cells. The expression levels
of NPPA, NPPB , mir-133 and CTGF were detected by RT-PCR. Mice were
injected with AAV-mir-133, AAV-mir-133-inhibitor or AAV-GFP at P0 days, and
the cardiac function of mice was detected by small animal high-frequency
echocardiography at P54 days. Double luciferase reporter plasmid was used
to verify the downstream target gene of mir-133.
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Results: By TAC surgery or inhibiting the expression of mir-133,
ultrasonic results showed that the heart LVPW was thickened in mice.
Immunofluorescence staining of myocardial tissue and single cardiomyocytes
showed hypertrophy of cardiomyocytes. The results of RT-PCR showed that
the expression level of NPPA was significantly increased after TAC surgery or
inhibiting the expression of mir-133. The dual luciferase reports showed that
mir-133 could inhibit the expression of CTGF to repress the cardiac hypertrophy.
The results of ultrasonic and immunofluorescence staining of myocardial tissue
and single myocardial cell were showed that the thickness of LVPW decreased
and the area of single myocardial cell decreased after the mice received TAC
when overexpression mir-133 by AAV9 vector.
Conclusion: Using AAV system could successfully repress or over express
the expression of mir-133, and overexpression of mir-133 could alleviate
myocardial hypertrophy induced by TAC surgery, via inhibiting the
expression of CTGF, which suggested mir-133 could be a potential
target for HCM treatment. The study successfully supply a new target
for gene therapy of HCM by using AAV system.
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Percutaneous Occlusion for Right Pulmonary Artery − Left
Atrium Fistula: A Case Report
X Zhang
Heart Center, Guangzhou Women and Children's Medical Center, Guangzhou,
China

solution possible. However, complications (e.g. RPA obstruction) should be
avoided. The size of device should be 2-4 mm larger than the stenosis of the
fistula.
Conclusion: Percutaneous occlusion of the rare congenital right PA − left
atrium fistula is safe and efficacious. The short term result is good. Long term
follow-up is needed.

Background: A five-year-old girl was presented to our center as cyanosis
and a rare congenital fistula from right pulmonary artery (PA) to left atrium, the
physical examination showed mild developmental delay with body weight of
16 kg. Severe cyanosis was noted with clubbed fingers, the percutaneous
oxygen saturation was 0.63, a 2/6 degree systolic murmur was heard at 2-3
intercostal area of the left border of sternum.
Case: A secondary polycythemia was noticed with an elevated hematocrit
(0.51), which clearly was the result of chronic hypoxia. The echocardiography
showed a RPA-LA fistula. The entrance of the fistula from the RPA was
9.4 mm, and the stenosis of the fistula was 6.4 mm. Heart catheterization and
angiography demonstrated that the fistula originated from the distal portion
of RPA and continued to the posterior wall of LA. The RPA joint of the fistula
was the narrowest point with a diameter of 5.6 mm. The mid-portion of the
fistula had ball-shaped expansion with the diameter of 18.3 mm. An 8 mm
CeraTM Atrial Septal Occluder was sent from the right femoral vein, across
the right atrium, the right ventricle, and the main and right PA, to close the
fistula at the RPA joint without any influence to the RPA blood flow. The
oxygen saturation elevated to 0.92 after occlusion. Aspirin was prescribed for
6 months. Follow-up echocardiography showed good early results.
Decision making: The prominent cyanosis was consistent with the indication
for invasive intervention. The special anatomy of the fistula made transcatheter

2
Percutaneous Dilation for Anastomotic Stenosis after Warden
Operation: A Case Report
X Zhang, SL Xia, LF Shang, YB Liu, X Zhang, XX Chen
Heart Center, Guangzhou Women and Children's Medical Center, Guangzhou,
China

Decision making: The diameter of the stenosis and the symptoms were
consistent with the indications for invasive intervention. The patient was at
high risk for repeated surgeries, so transcatheter solution was the first choice.
Our plan is balloon angioplasty first, then stenting if balloon could not work.
Conclusion: Balloon dilation is safe and efficacious for anastomotic stenosis
of SVC after Warden operation.

Background: A four-year-old girl was presented as prominent chest wall
varicosis. Her initial diagnosis was partial anomalous pulmonary venous
connection / atrial septal defect, with first stage "Warden operation" on
September 2016. Since June 2019, her chest wall superficial veins became
dilated and progressively aggravated.
Case: The echocardiogram showed that anastomosis between the superior
vena cava (SVC) and the right atrial appendage (RAA) was stenosed.
The diameter was 3.8 mm, the velocity of blood flow was 2.2 m/s.
Cardiac catheterization confirmed the diameter of anastomosis as
3.0 mm. Left innominate vein was 7.5 mm, right innominate vein was 9.4 mm,
azygous vein, semiazygous vein and accessory semiazygous vein were patent.
10 mm x 20 mm BALT balloon catheter was selected to dilate the narrowest
position for 3 times with the maximum pressure allowed. The stenosis was
relieved after dilation, with the diameter of the anastomosis enlarged to
7.6 mm, the left innominate vein 6.4 mm, and the right innominate vein 8.8 mm.
Echocardiography showed normal velocity at the anastomosis. The chest wall
varicosis disappeared after intervention.
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